<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Publisher PUBLIC "-//Springer-Verlag//DTD A++ V2.4//EN" "http://devel.springer.de/A++/V2.4/DTD/A++V2.4.dtd">
<Publisher>
  <PublisherInfo>
    <PublisherName>Springer-Verlag</PublisherName>
    <PublisherLocation>New York</PublisherLocation>
  </PublisherInfo>
  <Journal>
    <JournalInfo JournalProductType="ArchiveJournal" NumberingStyle="Unnumbered">
      <JournalID>12248</JournalID>
      <JournalElectronicISSN>1550-7416</JournalElectronicISSN>
      <JournalTitle>The AAPS Journal</JournalTitle>
      <JournalAbbreviatedTitle>AAPS J</JournalAbbreviatedTitle>
      <JournalSubjectGroup>
        <JournalSubject Code="F" Type="Primary">Pharmacy</JournalSubject>
        <JournalSubject Code="F00008" Priority="1" Type="Secondary">Pharmacy</JournalSubject>
        <JournalSubject Code="B21007" Priority="2" Type="Secondary">Pharmacology/Toxicology</JournalSubject>
        <JournalSubject Code="C12002" Priority="3" Type="Secondary">Biotechnology</JournalSubject>
      </JournalSubjectGroup>
    </JournalInfo>
    <Volume>
      <VolumeInfo TocLevels="0" VolumeType="Regular">
        <VolumeIDStart>7</VolumeIDStart>
        <VolumeIDEnd>7</VolumeIDEnd>
        <VolumeIssueCount>4</VolumeIssueCount>
      </VolumeInfo>
      <Issue IssueType="Regular">
        <IssueInfo TocLevels="0">
          <IssueIDStart>3</IssueIDStart>
          <IssueIDEnd>3</IssueIDEnd>
          <IssueArticleCount>25</IssueArticleCount>
          <IssueHistory>
            <CoverDate>
              <Year>2005</Year>
              <Month>9</Month>
            </CoverDate>
          </IssueHistory>
          <IssueCopyright>
            <CopyrightHolderName>American Association of Pharmaceutical Scientists</CopyrightHolderName>
            <CopyrightYear>2005</CopyrightYear>
          </IssueCopyright>
        </IssueInfo>
        <Article ID="Art21">
          <ArticleInfo ArticleType="OriginalPaper" ContainsESM="No" Language="En" NumberingStyle="Unnumbered" TocLevels="0">
            <ArticleID>73704</ArticleID>
            <ArticleDOI>10.1208/aapsj070371</ArticleDOI>
            <ArticleSequenceNumber>21</ArticleSequenceNumber>
            <ArticleTitle Language="En">Kappa opioid antagonists: Past successes and future prospects</ArticleTitle>
            <ArticleFirstPage>E704</ArticleFirstPage>
            <ArticleLastPage>E722</ArticleLastPage>
            <ArticleHistory>
              <RegistrationDate>
                <Year>2008</Year>
                <Month>1</Month>
                <Day>23</Day>
              </RegistrationDate>
              <Received>
                <Year>2005</Year>
                <Month>3</Month>
                <Day>10</Day>
              </Received>
              <Accepted>
                <Year>2005</Year>
                <Month>5</Month>
                <Day>30</Day>
              </Accepted>
            </ArticleHistory>
            <ArticleCopyright>
              <CopyrightHolderName>American Association of Pharmaceutical Scientists</CopyrightHolderName>
              <CopyrightYear>2005</CopyrightYear>
            </ArticleCopyright>
            <ArticleGrants Type="Regular">
              <MetadataGrant Grant="OpenAccess"/>
              <AbstractGrant Grant="OpenAccess"/>
              <BodyPDFGrant Grant="Restricted"/>
              <BodyHTMLGrant Grant="Restricted"/>
              <BibliographyGrant Grant="Restricted"/>
              <ESMGrant Grant="Restricted"/>
            </ArticleGrants>
            <ArticleContext>
              <JournalID>12248</JournalID>
              <VolumeIDStart>7</VolumeIDStart>
              <VolumeIDEnd>7</VolumeIDEnd>
              <IssueIDStart>3</IssueIDStart>
              <IssueIDEnd>3</IssueIDEnd>
            </ArticleContext>
          </ArticleInfo>
          <ArticleHeader>
            <AuthorGroup>
              <Author AffiliationIDS="Aff1">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Matthew</GivenName>
                  <GivenName>D.</GivenName>
                  <FamilyName>Metcalf</FamilyName>
                </AuthorName>
              </Author>
              <Author AffiliationIDS="Aff1" CorrespondingAffiliationID="Aff1">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Andrew</GivenName>
                  <FamilyName>Coop</FamilyName>
                </AuthorName>
                <Contact>
                  <Phone>(410)-706-2209</Phone>
                  <Fax>(410)-706-5017</Fax>
                  <Email>acoop@rx.umaryland.edu</Email>
                </Contact>
              </Author>
              <Affiliation ID="Aff1">
                <OrgDivision>Department of Pharmaceutical Sciences</OrgDivision>
                <OrgName>University of Maryland School of Pharmacy</OrgName>
                <OrgAddress>
                  <Street>20 Penn Street</Street>
                  <Postcode>21201</Postcode>
                  <City>Baltimore</City>
                  <State>MD</State>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
            <Abstract ID="Abs1" Language="En">
              <Heading>Abstract</Heading>
              <Para>Antagonists of the kappa opioid receptor were initially investigated as pharmacological tools that would reverse the effects of kappa opioid receptor agonists. In the years following the discovery of the first selective kappa opioid antagonists, much information about their chemistry and pharmacology has been elicited and their potential therapeutic uses have been investigated. The review presents the current chemistry, ligand-based structure activity relationships, and pharmacology of the known nonpeptidic selective kappa opioid receptor antagonists. This manuscript endeavors to provide the reader with a useful reference of the investigations made to define the structure-activity relationships and pharmacology of selective kappa opioid receptor antagonists and their potential uses as pharmacological tools and as therapeutic agents in the treatment of disease states.</Para>
            </Abstract>
            <KeywordGroup Language="En">
              <Heading>Keywords</Heading>
              <Keyword>Opioid</Keyword>
              <Keyword>Opiate</Keyword>
              <Keyword>Receptor</Keyword>
              <Keyword>Kappa</Keyword>
              <Keyword>Antagonist</Keyword>
            </KeywordGroup>
            <ArticleNote Type="Misc">
              <SimplePara>Published: October 27, 2005</SimplePara>
            </ArticleNote>
          </ArticleHeader>
          <BodyRef FileRef="BodyRef/PDF/12248_2008_Article_73704.pdf" TargetType="OnlinePDF"/>
          <ArticleBackmatter>
            <Bibliography ID="Bib1">
              <Heading>References</Heading>
              <Citation ID="CR1">
                <CitationNumber>1.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JB</Initials>
                    <FamilyName>Wang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PS</Initials>
                    <FamilyName>Johnson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AM</Initials>
                    <FamilyName>Persico</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AL</Initials>
                    <FamilyName>Hawkins</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CA</Initials>
                    <FamilyName>Griffin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>GR</Initials>
                    <FamilyName>Uhl</FamilyName>
                  </BibAuthorName>
                  <Year>1994</Year>
                  <ArticleTitle Language="En">Human mu opiate receptor—cDNA and genomic clones, pharmacologic characterization and chromosomal assignment</ArticleTitle>
                  <JournalTitle>FEBS Lett</JournalTitle>
                  <VolumeID>338</VolumeID>
                  <FirstPage>217</FirstPage>
                  <LastPage>222</LastPage>
                  <Occurrence Type="PID">
                    <Handle>7905839</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2cXhvVCgurc%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/0014-5793(94)80368-4</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Wang JB, Johnson PS, Persico AM, Hawkins AL, Griffin CA, Uhl GR. Human mu opiate receptor—cDNA and genomic clones, pharmacologic characterization and chromosomal assignment.<Emphasis Type="Italic">FEBS Lett</Emphasis>. 1994;338:217–222.</BibUnstructured>
              </Citation>
              <Citation ID="CR2">
                <CitationNumber>2.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Mansson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Bare</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Yang</FamilyName>
                  </BibAuthorName>
                  <Year>1994</Year>
                  <ArticleTitle Language="En">Isolation of a human kappa opioid receptor cDNA from placenta</ArticleTitle>
                  <JournalTitle>Biochem Biophys Res Commun</JournalTitle>
                  <VolumeID>202</VolumeID>
                  <FirstPage>1431</FirstPage>
                  <LastPage>1434</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8060324</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2cXmsVKmsbY%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1006/bbrc.1994.2091</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Mansson E, Bare L, Yang D. Isolation of a human kappa opioid receptor cDNA from placenta.<Emphasis Type="Italic">Biochem Biophys Res Commun</Emphasis>. 1994;202:1431–1434.</BibUnstructured>
              </Citation>
              <Citation ID="CR3">
                <CitationNumber>3.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>BL</Initials>
                    <FamilyName>Kieffer</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Befort</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Gavriaux-Ruff</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CG</Initials>
                    <FamilyName>Hirth</FamilyName>
                  </BibAuthorName>
                  <Year>1992</Year>
                  <ArticleTitle Language="En">The opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization</ArticleTitle>
                  <JournalTitle>Proc Natl Acad Sci USA</JournalTitle>
                  <VolumeID>89</VolumeID>
                  <FirstPage>12048</FirstPage>
                  <LastPage>12052</LastPage>
                  <Occurrence Type="PID">
                    <Handle>1334555</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK3sXkvVKnsrw%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1073/pnas.89.24.12048</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Kieffer BL, Befort K, Gavriaux-Ruff C, Hirth CG. The opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization.<Emphasis Type="Italic">Proc Natl Acad Sci USA</Emphasis>. 1992;89:12048–12052.</BibUnstructured>
              </Citation>
              <Citation ID="CR4">
                <CitationNumber>4.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>GR</Initials>
                    <FamilyName>Peters</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Gaylor</FamilyName>
                  </BibAuthorName>
                  <Year>1989</Year>
                  <ArticleTitle Language="En">Human central nervous system (CNS) effects of a selective kappa opioid agonist [abstract]</ArticleTitle>
                  <JournalTitle>Clin Pharmacol Ther.</JournalTitle>
                  <VolumeID>45</VolumeID>
                  <FirstPage>130</FirstPage>
                  <LastPage>130</LastPage>
                </BibArticle>
                <BibUnstructured>Peters GR, Gaylor S. Human central nervous system (CNS) effects of a selective kappa opioid agonist [abstract].<Emphasis Type="Italic">Clin Pharmacol Ther.</Emphasis> 1989;45:130.</BibUnstructured>
              </Citation>
              <Citation ID="CR5">
                <CitationNumber>5.</CitationNumber>
                <BibBook>
                  <BibAuthorName>
                    <Initials>AF</Initials>
                    <FamilyName>Casy</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RT</Initials>
                    <FamilyName>Parfitt</FamilyName>
                  </BibAuthorName>
                  <Year>1986</Year>
                  <BookTitle>Opioid Analgesics</BookTitle>
                  <PublisherName>Plenum Press</PublisherName>
                  <PublisherLocation>New York and London</PublisherLocation>
                </BibBook>
                <BibUnstructured>Casy AF, Parfitt RT.<Emphasis Type="Italic">Opioid Analgesics</Emphasis> New York and London: Plenum Press; 1986.</BibUnstructured>
              </Citation>
              <Citation ID="CR6">
                <CitationNumber>6.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Schmidhammer</FamilyName>
                  </BibAuthorName>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">Opioid receptor antagonists</ArticleTitle>
                  <JournalTitle>Prog Med Chem.</JournalTitle>
                  <VolumeID>35</VolumeID>
                  <FirstPage>83</FirstPage>
                  <LastPage>132</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10795400</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1cXltFSnt7o%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0079-6468(08)70035-3</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Schmidhammer H. Opioid receptor antagonists.<Emphasis Type="Italic">Prog Med Chem.</Emphasis> 1998;35:83–132.</BibUnstructured>
              </Citation>
              <Citation ID="CR7">
                <CitationNumber>7.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Coop</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KC</Initials>
                    <FamilyName>Rice</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Role of delta-opioid receptors in biological processes</ArticleTitle>
                  <JournalTitle>Drug News Perspect.</JournalTitle>
                  <VolumeID>13</VolumeID>
                  <FirstPage>481</FirstPage>
                  <LastPage>487</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12937621</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXmsFKksQ%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Coop A, Rice KC. Role of delta-opioid receptors in biological processes.<Emphasis Type="Italic">Drug News Perspect.</Emphasis> 2000;13:481–487.</BibUnstructured>
              </Citation>
              <Citation ID="CR8">
                <CitationNumber>8.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>DC</Initials>
                    <FamilyName>Rees</FamilyName>
                  </BibAuthorName>
                  <Year>1992</Year>
                  <ArticleTitle Language="En">Chemical structures and biological activities of nonpeptide selective kappa opioid ligands</ArticleTitle>
                  <JournalTitle>Prog Med Chem.</JournalTitle>
                  <VolumeID>29</VolumeID>
                  <FirstPage>109</FirstPage>
                  <LastPage>139</LastPage>
                  <Occurrence Type="PID">
                    <Handle>1335584</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK38Xks1ajtr8%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0079-6468(08)70006-7</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Rees DC. Chemical structures and biological activities of nonpeptide selective kappa opioid ligands.<Emphasis Type="Italic">Prog Med Chem.</Emphasis> 1992;29:109–139.</BibUnstructured>
              </Citation>
              <Citation ID="CR9">
                <CitationNumber>9.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>AV</Initials>
                    <FamilyName>Kuzmin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MAFM</Initials>
                    <FamilyName>Gerrits</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JM</Initials>
                    <FamilyName>Ree</FamilyName>
                    <Particle>Van</Particle>
                  </BibAuthorName>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">Kappa-opioid receptor blockade with nor-binaltorphimine modulates cocaine self-administration in drug-naïve rats</ArticleTitle>
                  <JournalTitle>Eur J Pharmacol.</JournalTitle>
                  <VolumeID>358</VolumeID>
                  <FirstPage>197</FirstPage>
                  <LastPage>202</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9822884</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1cXmslOgurk%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0014-2999(98)00637-2</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Kuzmin AV, Gerrits MAFM, Van Ree JM. Kappa-opioid receptor blockade with nor-binaltorphimine modulates cocaine self-administration in drug-naïve rats.<Emphasis Type="Italic">Eur J Pharmacol.</Emphasis> 1998;358:197–202.</BibUnstructured>
              </Citation>
              <Citation ID="CR10">
                <CitationNumber>10.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SD</Initials>
                    <FamilyName>Mague</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AM</Initials>
                    <FamilyName>Pliakas</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MS</Initials>
                    <FamilyName>Todtenkopf</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther.</JournalTitle>
                  <VolumeID>305</VolumeID>
                  <FirstPage>323</FirstPage>
                  <LastPage>330</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12649385</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXis1amsr8%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1124/jpet.102.046433</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Mague SD, Pliakas AM, Todtenkopf MS, et al. Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats.<Emphasis Type="Italic">J Pharmacol Exp Ther.</Emphasis> 2003;305:323–330.</BibUnstructured>
              </Citation>
              <Citation ID="CR11">
                <CitationNumber>11.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>DC</Initials>
                    <FamilyName>Jewett</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MK</Initials>
                    <FamilyName>Grace</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RM</Initials>
                    <FamilyName>Jones</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CJ</Initials>
                    <FamilyName>Billington</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PS</Initials>
                    <FamilyName>Portoghese</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AS</Initials>
                    <FamilyName>Levine</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">The kappa-opioid antagonist GNTI reduces U50,488-, DAMGO-, and deprivation-induced feeding, but not butorphanol-and neuropeptide-Y-induced feeding in rats</ArticleTitle>
                  <JournalTitle>Brain Res.</JournalTitle>
                  <VolumeID>909</VolumeID>
                  <FirstPage>75</FirstPage>
                  <LastPage>80</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11478923</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXls1ejs7o%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0006-8993(01)02624-5</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Jewett DC, Grace MK, Jones RM, Billington CJ, Portoghese PS, Levine AS. The kappa-opioid antagonist GNTI reduces U50,488-, DAMGO-, and deprivation-induced feeding, but not butorphanol-and neuropeptide-Y-induced feeding in rats.<Emphasis Type="Italic">Brain Res.</Emphasis> 2001;909:75–80.</BibUnstructured>
              </Citation>
              <Citation ID="CR12">
                <CitationNumber>12.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>BL</Initials>
                    <FamilyName>Roth</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Baner</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Westkaemper</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist</ArticleTitle>
                  <JournalTitle>Proc Natl Acad Sci USA</JournalTitle>
                  <VolumeID>99</VolumeID>
                  <FirstPage>11934</FirstPage>
                  <LastPage>11939</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12192085</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XntFWqtbY%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1073/pnas.182234399</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Roth BL, Baner K, Westkaemper R, et al. Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist.<Emphasis Type="Italic">Proc Natl Acad Sci USA</Emphasis>. 2002;99:11934–11939.</BibUnstructured>
              </Citation>
              <Citation ID="CR13">
                <CitationNumber>13.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Schmidhammer</FamilyName>
                  </BibAuthorName>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">Opioid receptor antagonists</ArticleTitle>
                  <JournalTitle>Prog Med Chem.</JournalTitle>
                  <VolumeID>35</VolumeID>
                  <FirstPage>83</FirstPage>
                  <LastPage>132</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10795400</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1cXltFSnt7o%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0079-6468(08)70035-3</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Schmidhammer H. Opioid receptor antagonists.<Emphasis Type="Italic">Prog Med Chem.</Emphasis> 1998;35:83–132.</BibUnstructured>
              </Citation>
              <Citation ID="CR14">
                <CitationNumber>14.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>MA</Initials>
                    <FamilyName>Bennett</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TF</Initials>
                    <FamilyName>Murray</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JV</Initials>
                    <FamilyName>Aldrich</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Identification of arodyn, a novel acetylated dynorphin A-(1–11) analogue, as a κ opioid receptor antagonist</ArticleTitle>
                  <JournalTitle>J Med Chem.</JournalTitle>
                  <VolumeID>45</VolumeID>
                  <FirstPage>5617</FirstPage>
                  <LastPage>5619</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12477343</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XovVChtL4%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1021/jm025575g</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Bennett MA, Murray TF, Aldrich JV. Identification of arodyn, a novel acetylated dynorphin A-(1–11) analogue, as a κ opioid receptor antagonist.<Emphasis Type="Italic">J Med Chem.</Emphasis> 2002;45:5617–5619.</BibUnstructured>
              </Citation>
              <Citation ID="CR15">
                <CitationNumber>15.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Weltrowska</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Lu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Lemieux</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>NN</Initials>
                    <FamilyName>Chung</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PW</Initials>
                    <FamilyName>Schiller</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">A novel cyclic enkephalin analogue with potent opioid antagonist activity</ArticleTitle>
                  <JournalTitle>Bioorg Med Chem Lett.</JournalTitle>
                  <VolumeID>14</VolumeID>
                  <FirstPage>4731</FirstPage>
                  <LastPage>4733</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15324897</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXmvV2ht7c%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.bmcl.2004.06.077</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Weltrowska G, Lu Y, Lemieux C, Chung NN, Schiller PW. A novel cyclic enkephalin analogue with potent opioid antagonist activity.<Emphasis Type="Italic">Bioorg Med Chem Lett.</Emphasis> 2004;14:4731–4733.</BibUnstructured>
              </Citation>
              <Citation ID="CR16">
                <CitationNumber>16.</CitationNumber>
                <BibChapter>
                  <BibAuthorName>
                    <Initials>JV</Initials>
                    <FamilyName>Aldrich</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ChapterTitle Language="En">Analgesics</ChapterTitle>
                  <BibEditorName>
                    <Initials>DJ</Initials>
                    <FamilyName>Abraham</FamilyName>
                  </BibEditorName>
                  <Eds/>
                  <BookTitle>Burger’s Medicinal Chemistry and Drug Discovery, Volume 6, Nervous System Agents</BookTitle>
                  <EditionNumber>6th ed.</EditionNumber>
                  <PublisherName>John Wiley and Sons</PublisherName>
                  <PublisherLocation>New York</PublisherLocation>
                  <FirstPage>329</FirstPage>
                  <LastPage>482</LastPage>
                </BibChapter>
                <BibUnstructured>Aldrich JV. Analgesics. In: Abraham DJ, ed.<Emphasis Type="Italic">Burger’s Medicinal Chemistry and Drug Discovery, Volume 6, Nervous System Agents</Emphasis>. 6<Superscript>th</Superscript> ed. New York: John Wiley and Sons; 2003:329–482.</BibUnstructured>
              </Citation>
              <Citation ID="CR17">
                <CitationNumber>17.</CitationNumber>
                <BibBook>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Cowan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JW</Initials>
                    <FamilyName>Lewis</FamilyName>
                  </BibAuthorName>
                  <Year>1995</Year>
                  <BookTitle>Buprenorphine: Combatting Drug Abuse with a Unique Opioid</BookTitle>
                  <PublisherName>John Wiley and Sons</PublisherName>
                  <PublisherLocation>New York</PublisherLocation>
                </BibBook>
                <BibUnstructured>Cowan A, Lewis JW.<Emphasis Type="Italic">Buprenorphine: Combatting Drug Abuse with a Unique Opioid</Emphasis>. New York: John Wiley and Sons; 1995.</BibUnstructured>
              </Citation>
              <Citation ID="CR18">
                <CitationNumber>18.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>LA</Initials>
                    <FamilyName>Devi</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Heterodimerization of G-protein-coupled receptors: pharmacology, signaling, and trafficking</ArticleTitle>
                  <JournalTitle>Trends Pharmacol Sci.</JournalTitle>
                  <VolumeID>22</VolumeID>
                  <FirstPage>532</FirstPage>
                  <LastPage>537</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11583811</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXnt1Wisbw%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0165-6147(00)01799-5</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Devi LA. Heterodimerization of G-protein-coupled receptors: pharmacology, signaling, and trafficking.<Emphasis Type="Italic">Trends Pharmacol Sci.</Emphasis> 2001;22:532–537.</BibUnstructured>
              </Citation>
              <Citation ID="CR19">
                <CitationNumber>19.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>DE</Initials>
                    <FamilyName>Rusovici</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SS</Initials>
                    <FamilyName>Negus</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>NK</Initials>
                    <FamilyName>Mello</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JM</Initials>
                    <FamilyName>Bidlack</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">κ-opioid receptors are differentially labeled by arylacetamides and benzomorphans</ArticleTitle>
                  <JournalTitle>Eur J Pharmacol.</JournalTitle>
                  <VolumeID>485</VolumeID>
                  <FirstPage>119</FirstPage>
                  <LastPage>125</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14757131</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXnvVyisA%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.ejphar.2003.11.078</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Rusovici DE, Negus SS, Mello NK, Bidlack JM. κ-opioid receptors are differentially labeled by arylacetamides and benzomorphans.<Emphasis Type="Italic">Eur J Pharmacol.</Emphasis> 2004;485:119–125.</BibUnstructured>
              </Citation>
              <Citation ID="CR20">
                <CitationNumber>20.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>DM</Initials>
                    <FamilyName>Zimmerman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JD</Initials>
                    <FamilyName>Leander</FamilyName>
                  </BibAuthorName>
                  <Year>1990</Year>
                  <ArticleTitle Language="En">Selective opioid receptor agonists and antagonists: research tools and potential therapeutic agents</ArticleTitle>
                  <JournalTitle>J Med Chem.</JournalTitle>
                  <VolumeID>33</VolumeID>
                  <FirstPage>895</FirstPage>
                  <LastPage>902</LastPage>
                  <Occurrence Type="PID">
                    <Handle>2155322</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK3cXhtFWhu7s%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1021/jm00165a002</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Zimmerman DM, Leander JD. Selective opioid receptor agonists and antagonists: research tools and potential therapeutic agents.<Emphasis Type="Italic">J Med Chem.</Emphasis> 1990;33:895–902.</BibUnstructured>
              </Citation>
              <Citation ID="CR21">
                <CitationNumber>21.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>DL</Initials>
                    <FamilyName>Larson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RM</Initials>
                    <FamilyName>Jones</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SA</Initials>
                    <FamilyName>Hjorth</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TW</Initials>
                    <FamilyName>Schwartz</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PS</Initials>
                    <FamilyName>Portoghese</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Binding of norbinaltorphimine (norBNI) congeners to wild-type and mutant mu and kappa opioid receptors: molecular recognition loci for the pharmacophore and address components of kappa antagonists</ArticleTitle>
                  <JournalTitle>J Med Chem.</JournalTitle>
                  <VolumeID>43</VolumeID>
                  <FirstPage>1573</FirstPage>
                  <LastPage>1576</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10780914</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXitVGnur8%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1021/jm000059g</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Larson DL, Jones RM, Hjorth SA, Schwartz TW, Portoghese PS. Binding of norbinaltorphimine (norBNI) congeners to wild-type and mutant mu and kappa opioid receptors: molecular recognition loci for the pharmacophore and address components of kappa antagonists.<Emphasis Type="Italic">J Med Chem.</Emphasis> 2000;43:1573–1576.</BibUnstructured>
              </Citation>
              <Citation ID="CR22">
                <CitationNumber>22.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>RM</Initials>
                    <FamilyName>Jones</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SA</Initials>
                    <FamilyName>Hjorth</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TW</Initials>
                    <FamilyName>Schwartz</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PS</Initials>
                    <FamilyName>Portoghese</FamilyName>
                  </BibAuthorName>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">Mutational evidence for a common κ antagonist binding pocket in the wild-type κ and mutant μ[K303E] opioid receptors</ArticleTitle>
                  <JournalTitle>J Med Chem.</JournalTitle>
                  <VolumeID>41</VolumeID>
                  <FirstPage>4911</FirstPage>
                  <LastPage>4914</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9836606</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1cXnt12ju70%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1021/jm9805182</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Jones RM, Hjorth SA, Schwartz TW, Portoghese PS. Mutational evidence for a common κ antagonist binding pocket in the wild-type κ and mutant μ[K303E] opioid receptors.<Emphasis Type="Italic">J Med Chem.</Emphasis> 1998;41:4911–4914.</BibUnstructured>
              </Citation>
              <Citation ID="CR23">
                <CitationNumber>23.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SK</Initials>
                    <FamilyName>Sharma</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RM</Initials>
                    <FamilyName>Jones</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TG</Initials>
                    <FamilyName>Metzger</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DM</Initials>
                    <FamilyName>Ferguson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PS</Initials>
                    <FamilyName>Portoghese</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Transformation of a κ-opioid receptor antagonist to a κ-agonist by transfer of a guanidinium group form the 5′-to the 6′-position of naltrindole</ArticleTitle>
                  <JournalTitle>J Med Chem.</JournalTitle>
                  <VolumeID>44</VolumeID>
                  <FirstPage>2073</FirstPage>
                  <LastPage>2079</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11405645</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXjvVWjsbY%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1021/jm010095v</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Sharma SK, Jones RM, Metzger TG, Ferguson DM, Portoghese PS. Transformation of a κ-opioid receptor antagonist to a κ-agonist by transfer of a guanidinium group form the 5′-to the 6′-position of naltrindole.<Emphasis Type="Italic">J Med Chem.</Emphasis> 2001;44:2073–2079.</BibUnstructured>
              </Citation>
              <Citation ID="CR24">
                <CitationNumber>24.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>WC</Initials>
                    <FamilyName>Stevens</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RM</Initials>
                    <FamilyName>Jones</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Subramanian</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TG</Initials>
                    <FamilyName>Metzger</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DM</Initials>
                    <FamilyName>Ferguson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PS</Initials>
                    <FamilyName>Portoghese</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Potent and selective indolomorphinan antagonists of the kappa-opioid receptor</ArticleTitle>
                  <JournalTitle>J Med Chem.</JournalTitle>
                  <VolumeID>43</VolumeID>
                  <FirstPage>2759</FirstPage>
                  <LastPage>2769</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10893314</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXktVGltLc%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1021/jm0000665</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Stevens WC, Jones RM, Subramanian G, Metzger TG, Ferguson DM, Portoghese PS. Potent and selective indolomorphinan antagonists of the kappa-opioid receptor.<Emphasis Type="Italic">J Med Chem.</Emphasis> 2000;43:2759–2769.</BibUnstructured>
              </Citation>
              <Citation ID="CR25">
                <CitationNumber>25.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>TG</Initials>
                    <FamilyName>Metzger</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MG</Initials>
                    <FamilyName>Paterlini</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DM</Initials>
                    <FamilyName>Ferguson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PS</Initials>
                    <FamilyName>Portoghese</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Investigation of the selectivity of oxymorphone- and naltrexone-derived ligands via site directed mutagenesis of opioid receptors: exploring the ‘address’ recognition locus</ArticleTitle>
                  <JournalTitle>J Med Chem.</JournalTitle>
                  <VolumeID>44</VolumeID>
                  <FirstPage>857</FirstPage>
                  <LastPage>862</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11300867</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXhtFygu7k%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1021/jm000381r</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Metzger TG, Paterlini MG, Ferguson DM, Portoghese PS. Investigation of the selectivity of oxymorphone- and naltrexone-derived ligands via site directed mutagenesis of opioid receptors: exploring the ‘address’ recognition locus.<Emphasis Type="Italic">J Med Chem.</Emphasis> 2001;44:857–862.</BibUnstructured>
              </Citation>
              <Citation ID="CR26">
                <CitationNumber>26.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Kong</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Raynor</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Yano</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Takeda</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>GI</Initials>
                    <FamilyName>Bell</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Reisine</FamilyName>
                  </BibAuthorName>
                  <Year>1994</Year>
                  <ArticleTitle Language="En">Agonists and antagonists bind to different domanins of the cloned κ opioid receptor</ArticleTitle>
                  <JournalTitle>Proc Natl Acad Sci USA</JournalTitle>
                  <VolumeID>91</VolumeID>
                  <FirstPage>8042</FirstPage>
                  <LastPage>8046</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8058754</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2cXlsVyqtbk%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1073/pnas.91.17.8042</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Kong H, Raynor K, Yano H, Takeda J, Bell GI, Reisine T. Agonists and antagonists bind to different domanins of the cloned κ opioid receptor.<Emphasis Type="Italic">Proc Natl Acad Sci USA</Emphasis>. 1994;91:8042–8046.</BibUnstructured>
              </Citation>
              <Citation ID="CR27">
                <CitationNumber>27.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SA</Initials>
                    <FamilyName>Hjorth</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Thirstrup</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DK</Initials>
                    <FamilyName>Grandy</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TW</Initials>
                    <FamilyName>Schwartz</FamilyName>
                  </BibAuthorName>
                  <Year>1995</Year>
                  <ArticleTitle Language="En">Analysis of selective binding epitopes for the κ-opioids receptor antagonist nor-binaltorphimine</ArticleTitle>
                  <JournalTitle>Mol Pharmacol.</JournalTitle>
                  <VolumeID>47</VolumeID>
                  <FirstPage>1089</FirstPage>
                  <LastPage>1094</LastPage>
                  <Occurrence Type="PID">
                    <Handle>7541509</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2MXmslejtbk%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Hjorth SA, Thirstrup K, Grandy DK, Schwartz TW. Analysis of selective binding epitopes for the κ-opioids receptor antagonist nor-binaltorphimine.<Emphasis Type="Italic">Mol Pharmacol.</Emphasis> 1995;47:1089–1094.</BibUnstructured>
              </Citation>
              <Citation ID="CR28">
                <CitationNumber>28.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Eguchi</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Recent Advances in selective opioid receptor agonists and antagonists</ArticleTitle>
                  <JournalTitle>Med Res Rev.</JournalTitle>
                  <VolumeID>24</VolumeID>
                  <FirstPage>182</FirstPage>
                  <LastPage>212</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14705168</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXitlelsrw%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/med.10059</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Eguchi M. Recent Advances in selective opioid receptor agonists and antagonists.<Emphasis Type="Italic">Med Res Rev.</Emphasis> 2004;24:182–212.</BibUnstructured>
              </Citation>
              <Citation ID="CR29">
                <CitationNumber>29.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>PS</Initials>
                    <FamilyName>Portoghese</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AW</Initials>
                    <FamilyName>Lipkowski</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AE</Initials>
                    <FamilyName>Takemori</FamilyName>
                  </BibAuthorName>
                  <Year>1987</Year>
                  <ArticleTitle Language="En">Binaltorphimine and nor-binaltorphimine, potent and selective κ-opioid receptor antagonists</ArticleTitle>
                  <JournalTitle>Life Sci.</JournalTitle>
                  <VolumeID>40</VolumeID>
                  <FirstPage>1287</FirstPage>
                  <LastPage>1292</LastPage>
                  <Occurrence Type="PID">
                    <Handle>2882399</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaL2sXksFWku7s%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/0024-3205(87)90585-6</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Portoghese PS, Lipkowski AW, Takemori AE. Binaltorphimine and nor-binaltorphimine, potent and selective κ-opioid receptor antagonists.<Emphasis Type="Italic">Life Sci.</Emphasis> 1987;40:1287–1292.</BibUnstructured>
              </Citation>
              <Citation ID="CR30">
                <CitationNumber>30.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>ER</Initials>
                    <FamilyName>Butelman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TJ</Initials>
                    <FamilyName>Harris</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MJ</Initials>
                    <FamilyName>Kreek</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">The plant-derived hallucinogen, salvinorin A, produces kappa-opioid agonist-like discriminative effects in rhesus monkeys</ArticleTitle>
                  <JournalTitle>Psychopharmacology (Berl)</JournalTitle>
                  <VolumeID>172</VolumeID>
                  <FirstPage>220</FirstPage>
                  <LastPage>224</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXhsFyktLk%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1007/s00213-003-1638-0</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Butelman ER, Harris TJ, Kreek MJ. The plant-derived hallucinogen, salvinorin A, produces kappa-opioid agonist-like discriminative effects in rhesus monkeys.<Emphasis Type="Italic">Psychopharmacology (Berl)</Emphasis>. 2004;172:220–224.</BibUnstructured>
              </Citation>
              <Citation ID="CR31">
                <CitationNumber>31.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Erez</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AE</Initials>
                    <FamilyName>Takemori</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PS</Initials>
                    <FamilyName>Portoghese</FamilyName>
                  </BibAuthorName>
                  <Year>1982</Year>
                  <ArticleTitle Language="En">Narcotic antagonistic potency of bivalent ligands which contain β-naltrexamine. Evidence for bridging between proximal recognition sites</ArticleTitle>
                  <JournalTitle>J Med Chem.</JournalTitle>
                  <VolumeID>25</VolumeID>
                  <FirstPage>847</FirstPage>
                  <LastPage>849</LastPage>
                  <Occurrence Type="PID">
                    <Handle>7108900</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaL38XktVSmurY%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1021/jm00349a016</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Erez M, Takemori AE, Portoghese PS. Narcotic antagonistic potency of bivalent ligands which contain β-naltrexamine. Evidence for bridging between proximal recognition sites.<Emphasis Type="Italic">J Med Chem.</Emphasis> 1982;25:847–849.</BibUnstructured>
              </Citation>
              <Citation ID="CR32">
                <CitationNumber>32.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>PS</Initials>
                    <FamilyName>Portoghese</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AE</Initials>
                    <FamilyName>Takemori</FamilyName>
                  </BibAuthorName>
                  <Year>1985</Year>
                  <ArticleTitle Language="En">TENA, a selective kappa opioid receptor antagonist</ArticleTitle>
                  <JournalTitle>Life Sci.</JournalTitle>
                  <VolumeID>36</VolumeID>
                  <FirstPage>801</FirstPage>
                  <LastPage>805</LastPage>
                  <Occurrence Type="PID">
                    <Handle>2983171</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaL2MXhvFOrs78%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/0024-3205(85)90202-4</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Portoghese PS, Takemori AE. TENA, a selective kappa opioid receptor antagonist.<Emphasis Type="Italic">Life Sci.</Emphasis> 1985;36:801–805.</BibUnstructured>
              </Citation>
              <Citation ID="CR33">
                <CitationNumber>33.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Botros</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AW</Initials>
                    <FamilyName>Lipkowski</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AE</Initials>
                    <FamilyName>Takemori</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PS</Initials>
                    <FamilyName>Portoghese</FamilyName>
                  </BibAuthorName>
                  <Year>1986</Year>
                  <ArticleTitle Language="En">Investigation of the structural requirements for the κ-selective opioid receptor antagonist, 6β,6β′-[ethlenebis(oxyethyleneimino)]bis[17-(cyclopropylmethyl)-4,5α-epoxymorphinan-3,14-diol] (TENA)</ArticleTitle>
                  <JournalTitle>J Med Chem.</JournalTitle>
                  <VolumeID>29</VolumeID>
                  <FirstPage>874</FirstPage>
                  <LastPage>876</LastPage>
                  <Occurrence Type="PID">
                    <Handle>3009817</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaL28Xit1Gjtbo%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1021/jm00155a048</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Botros S, Lipkowski AW, Takemori AE, Portoghese PS. Investigation of the structural requirements for the κ-selective opioid receptor antagonist, 6β,6β′-[ethlenebis(oxyethyleneimino)]bis[17-(cyclopropylmethyl)-4,5α-epoxymorphinan-3,14-diol] (TENA).<Emphasis Type="Italic">J Med Chem.</Emphasis> 1986;29:874–876.</BibUnstructured>
              </Citation>
              <Citation ID="CR34">
                <CitationNumber>34.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>PS</Initials>
                    <FamilyName>Portoghese</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Ronsisvalle</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DL</Initials>
                    <FamilyName>Larson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AE</Initials>
                    <FamilyName>Takemori</FamilyName>
                  </BibAuthorName>
                  <Year>1986</Year>
                  <ArticleTitle Language="En">Synthesis and opioid antagonist potencies of naltrexamine bivalent ligands with conformationally restricted spacers</ArticleTitle>
                  <JournalTitle>J Med Chem.</JournalTitle>
                  <VolumeID>29</VolumeID>
                  <FirstPage>1650</FirstPage>
                  <LastPage>1653</LastPage>
                  <Occurrence Type="PID">
                    <Handle>3018242</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaL28XmtV2htrw%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1021/jm00159a014</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Portoghese PS, Ronsisvalle G, Larson DL, Takemori AE. Synthesis and opioid antagonist potencies of naltrexamine bivalent ligands with conformationally restricted spacers.<Emphasis Type="Italic">J Med Chem.</Emphasis> 1986;29:1650–1653.</BibUnstructured>
              </Citation>
              <Citation ID="CR35">
                <CitationNumber>35.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>PS</Initials>
                    <FamilyName>Portoghese</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DL</Initials>
                    <FamilyName>Larson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LM</Initials>
                    <FamilyName>Sayre</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1986</Year>
                  <ArticleTitle Language="En">Opioid agonist and antagonist bivalent ligands. The relationship between spacer length and selectivity at multiple opioid receptors</ArticleTitle>
                  <JournalTitle>J Med Chem.</JournalTitle>
                  <VolumeID>29</VolumeID>
                  <FirstPage>1855</FirstPage>
                  <LastPage>1861</LastPage>
                  <Occurrence Type="PID">
                    <Handle>3020244</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaL2sXhvVyqug%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1021/jm00160a010</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Portoghese PS, Larson DL, Sayre LM, et al. Opioid agonist and antagonist bivalent ligands. The relationship between spacer length and selectivity at multiple opioid receptors.<Emphasis Type="Italic">J Med Chem.</Emphasis> 1986;29:1855–1861.</BibUnstructured>
              </Citation>
              <Citation ID="CR36">
                <CitationNumber>36.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>AS</Initials>
                    <FamilyName>Portoghese</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AW</Initials>
                    <FamilyName>Lipkowski</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AE</Initials>
                    <FamilyName>Takemori</FamilyName>
                  </BibAuthorName>
                  <Year>1987</Year>
                  <ArticleTitle Language="En">Bimorphinans as highly selective, potent κ opioid receptor antagonists</ArticleTitle>
                  <JournalTitle>J Med Chem.</JournalTitle>
                  <VolumeID>30</VolumeID>
                  <FirstPage>238</FirstPage>
                  <LastPage>239</LastPage>
                  <Occurrence Type="PID">
                    <Handle>3027336</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaL2sXktlyjtA%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1021/jm00385a002</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Portoghese AS, Lipkowski AW, Takemori AE. Bimorphinans as highly selective, potent κ opioid receptor antagonists.<Emphasis Type="Italic">J Med Chem.</Emphasis> 1987;30:238–239.</BibUnstructured>
              </Citation>
              <Citation ID="CR37">
                <CitationNumber>37.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>AE</Initials>
                    <FamilyName>Takemori</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PS</Initials>
                    <FamilyName>Portoghese</FamilyName>
                  </BibAuthorName>
                  <Year>1992</Year>
                  <ArticleTitle Language="En">Selective naltrexone-derived opioid receptor antagonists</ArticleTitle>
                  <JournalTitle>Annu Rev Pharmacol Toxicol.</JournalTitle>
                  <VolumeID>32</VolumeID>
                  <FirstPage>239</FirstPage>
                  <LastPage>269</LastPage>
                  <Occurrence Type="PID">
                    <Handle>1318671</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK38XisVOktrg%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1146/annurev.pa.32.040192.001323</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Takemori AE, Portoghese PS. Selective naltrexone-derived opioid receptor antagonists.<Emphasis Type="Italic">Annu Rev Pharmacol Toxicol.</Emphasis> 1992;32:239–269.</BibUnstructured>
              </Citation>
              <Citation ID="CR38">
                <CitationNumber>38.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>PS</Initials>
                    <FamilyName>Portoghese</FamilyName>
                  </BibAuthorName>
                  <Year>1989</Year>
                  <ArticleTitle Language="En">Bivalent ligands and the message-address concept in the design of selective opioid receptor antagonists</ArticleTitle>
                  <JournalTitle>Trends Pharmacol Sci.</JournalTitle>
                  <VolumeID>10</VolumeID>
                  <FirstPage>230</FirstPage>
                  <LastPage>235</LastPage>
                  <Occurrence Type="PID">
                    <Handle>2549665</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaL1MXkslSisLk%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/0165-6147(89)90267-8</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Portoghese PS. Bivalent ligands and the message-address concept in the design of selective opioid receptor antagonists.<Emphasis Type="Italic">Trends Pharmacol Sci.</Emphasis> 1989;10:230–235.</BibUnstructured>
              </Citation>
              <Citation ID="CR39">
                <CitationNumber>39.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Schwyzer</FamilyName>
                  </BibAuthorName>
                  <Year>1977</Year>
                  <ArticleTitle Language="En">ACTH: a short introductory review</ArticleTitle>
                  <JournalTitle>Ann NY Acad Sci.</JournalTitle>
                  <VolumeID>297</VolumeID>
                  <FirstPage>3</FirstPage>
                  <LastPage>26</LastPage>
                  <Occurrence Type="PID">
                    <Handle>211904</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaE1cXjt1Wquw%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1111/j.1749-6632.1977.tb41843.x</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Schwyzer R. ACTH: a short introductory review.<Emphasis Type="Italic">Ann NY Acad Sci.</Emphasis> 1977;297:3–26.</BibUnstructured>
              </Citation>
              <Citation ID="CR40">
                <CitationNumber>40.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Lin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AE</Initials>
                    <FamilyName>Takemori</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PS</Initials>
                    <FamilyName>Portoghese</FamilyName>
                  </BibAuthorName>
                  <Year>1993</Year>
                  <ArticleTitle Language="En">Synthesis and κ-opioid antagonist selectivity of a norbinaltorphimine congener. Identification of the address moiety reqired for κ-antagonist activity</ArticleTitle>
                  <JournalTitle>J Med Chem.</JournalTitle>
                  <VolumeID>36</VolumeID>
                  <FirstPage>2412</FirstPage>
                  <LastPage>2415</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8360887</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK3sXltl2muro%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1021/jm00068a020</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Lin C, Takemori AE, Portoghese PS. Synthesis and κ-opioid antagonist selectivity of a norbinaltorphimine congener. Identification of the address moiety reqired for κ-antagonist activity.<Emphasis Type="Italic">J Med Chem.</Emphasis> 1993;36:2412–2415.</BibUnstructured>
              </Citation>
              <Citation ID="CR41">
                <CitationNumber>41.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JB</Initials>
                    <FamilyName>Thomas</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RN</Initials>
                    <FamilyName>Atkinson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Vinson</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Identification of (3R)-7-Hydroxy-<Emphasis Type="Italic">N</Emphasis>-((1S)-1-{[(3R, 4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl}-2-methylpropyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide as a novel potent and selective opioid κ receptor antagonist</ArticleTitle>
                  <JournalTitle>J Med Chem.</JournalTitle>
                  <VolumeID>46</VolumeID>
                  <FirstPage>3127</FirstPage>
                  <LastPage>3137</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12825951</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXksVChsb0%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1021/jm030094y</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Thomas JB, Atkinson RN, Vinson A, et al. Identification of (3R)-7-Hydroxy-<Emphasis Type="Italic">N</Emphasis>-((1S)-1-{[(3R, 4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl}-2-methylpropyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide as a novel potent and selective opioid κ receptor antagonist.<Emphasis Type="Italic">J Med Chem.</Emphasis> 2003;46:3127–3137.</BibUnstructured>
              </Citation>
              <Citation ID="CR42">
                <CitationNumber>42.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Grundt</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>IA</Initials>
                    <FamilyName>Williams</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JW</Initials>
                    <FamilyName>Lewis</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SM</Initials>
                    <FamilyName>Husbands</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Identification of a new scaffold for κ opioid receptor antagonism based on the 2-amino-1, 1-dimethyl-7-hydroxytetralin pharmacophore</ArticleTitle>
                  <JournalTitle>J Med Chem.</JournalTitle>
                  <VolumeID>47</VolumeID>
                  <FirstPage>5069</FirstPage>
                  <LastPage>5075</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15456250</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXnt12gtrY%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1021/jm040807s</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Grundt P, Williams IA, Lewis JW, Husbands SM. Identification of a new scaffold for κ opioid receptor antagonism based on the 2-amino-1, 1-dimethyl-7-hydroxytetralin pharmacophore.<Emphasis Type="Italic">J Med Chem.</Emphasis> 2004;47:5069–5075.</BibUnstructured>
              </Citation>
              <Citation ID="CR43">
                <CitationNumber>43.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>PS</Initials>
                    <FamilyName>Portoghese</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Nagase</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AE</Initials>
                    <FamilyName>Takemori</FamilyName>
                  </BibAuthorName>
                  <Year>1988</Year>
                  <ArticleTitle Language="En">Only one pharmacophore is required for the κ opioid antagonist selectivity of norbinaltorphimine</ArticleTitle>
                  <JournalTitle>J Med Chem.</JournalTitle>
                  <VolumeID>31</VolumeID>
                  <FirstPage>1344</FirstPage>
                  <LastPage>1347</LastPage>
                  <Occurrence Type="PID">
                    <Handle>2838632</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaL1cXktFKmtbk%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1021/jm00402a015</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Portoghese PS, Nagase H, Takemori AE. Only one pharmacophore is required for the κ opioid antagonist selectivity of norbinaltorphimine.<Emphasis Type="Italic">J Med Chem.</Emphasis> 1988;31:1344–1347.</BibUnstructured>
              </Citation>
              <Citation ID="CR44">
                <CitationNumber>44.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>PS</Initials>
                    <FamilyName>Portoghese</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Nagase</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AW</Initials>
                    <FamilyName>Lipkowski</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DL</Initials>
                    <FamilyName>Larson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AE</Initials>
                    <FamilyName>Takemori</FamilyName>
                  </BibAuthorName>
                  <Year>1988</Year>
                  <ArticleTitle Language="En">Binaltorphimine-related bivalent ligands and their κ opioid receptor antagonist selectivity</ArticleTitle>
                  <JournalTitle>J Med Chem.</JournalTitle>
                  <VolumeID>31</VolumeID>
                  <FirstPage>836</FirstPage>
                  <LastPage>841</LastPage>
                  <Occurrence Type="PID">
                    <Handle>2832604</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaL1cXhsFSktb8%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1021/jm00399a026</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Portoghese PS, Nagase H, Lipkowski AW, Larson DL, Takemori AE. Binaltorphimine-related bivalent ligands and their κ opioid receptor antagonist selectivity.<Emphasis Type="Italic">J Med Chem.</Emphasis> 1988;31:836–841.</BibUnstructured>
              </Citation>
              <Citation ID="CR45">
                <CitationNumber>45.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Schmidhammer</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Ganglbauer</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Mitterdorfer</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JM</Initials>
                    <FamilyName>Rollinger</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CFC</Initials>
                    <FamilyName>Smith</FamilyName>
                  </BibAuthorName>
                  <Year>1990</Year>
                  <ArticleTitle Language="En">Synthesis and biological evaluation of 14-alkoxymorphinans 14,14′-dimethoxy analogues of norbinaltorphimine: synthesis and determination of their κ opioid antagonist selectivity</ArticleTitle>
                  <JournalTitle>Helv Chim Acta.</JournalTitle>
                  <VolumeID>73</VolumeID>
                  <FirstPage>1779</FirstPage>
                  <LastPage>1783</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK3MXhvVGrsrg%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/hlca.19900730622</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Schmidhammer H, Ganglbauer E, Mitterdorfer J, Rollinger JM, Smith CFC. Synthesis and biological evaluation of 14-alkoxymorphinans 14,14′-dimethoxy analogues of norbinaltorphimine: synthesis and determination of their κ opioid antagonist selectivity.<Emphasis Type="Italic">Helv Chim Acta.</Emphasis> 1990;73:1779–1783.</BibUnstructured>
              </Citation>
              <Citation ID="CR46">
                <CitationNumber>46.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Schmidhammer</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CFC</Initials>
                    <FamilyName>Smith</FamilyName>
                  </BibAuthorName>
                  <Year>1989</Year>
                  <ArticleTitle Language="En">A simple and efficient method for the preparation of binaltorphimine and derivatives and determination of their κ opioid antagonist selectivity</ArticleTitle>
                  <JournalTitle>Helv Chim Acta</JournalTitle>
                  <VolumeID>72</VolumeID>
                  <FirstPage>675</FirstPage>
                  <LastPage>677</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK3cXhsl2mtbc%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/hlca.19890720408</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Schmidhammer H, Smith CFC. A simple and efficient method for the preparation of binaltorphimine and derivatives and determination of their κ opioid antagonist selectivity.<Emphasis Type="Italic">Helv Chim Acta</Emphasis>. 1989;72:675–677.</BibUnstructured>
              </Citation>
              <Citation ID="CR47">
                <CitationNumber>47.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>PS</Initials>
                    <FamilyName>Portoghese</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Garzon-Aburbeh</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Nagase</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Lin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AE</Initials>
                    <FamilyName>Takemori</FamilyName>
                  </BibAuthorName>
                  <Year>1991</Year>
                  <ArticleTitle Language="En">Role of the spacer in conferring κ opioid receptor selectivity to bivalent ligands related to norbinaltorphimine</ArticleTitle>
                  <JournalTitle>J Med Chem.</JournalTitle>
                  <VolumeID>34</VolumeID>
                  <FirstPage>1292</FirstPage>
                  <LastPage>1296</LastPage>
                  <Occurrence Type="PID">
                    <Handle>1849995</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK3MXhvVGrsrs%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1021/jm00108a008</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Portoghese PS, Garzon-Aburbeh A, Nagase H, Lin C, Takemori AE. Role of the spacer in conferring κ opioid receptor selectivity to bivalent ligands related to norbinaltorphimine.<Emphasis Type="Italic">J Med Chem.</Emphasis> 1991;34:1292–1296.</BibUnstructured>
              </Citation>
              <Citation ID="CR48">
                <CitationNumber>48.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>PS</Initials>
                    <FamilyName>Portoghese</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Lin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Farouz-Grant</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AE</Initials>
                    <FamilyName>Takemori</FamilyName>
                  </BibAuthorName>
                  <Year>1994</Year>
                  <ArticleTitle Language="En">Structure-activity relationship of N17′substituted norbinaltorphimine congeners. Role of the N17′ basic group in the interaction with a putative address subsite on the κ opioid receptor</ArticleTitle>
                  <JournalTitle>J Med Chem.</JournalTitle>
                  <VolumeID>37</VolumeID>
                  <FirstPage>1495</FirstPage>
                  <LastPage>1500</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8182708</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2cXktV2kurY%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1021/jm00036a015</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Portoghese PS, Lin C, Farouz-Grant R, Takemori AE. Structure-activity relationship of N17′substituted norbinaltorphimine congeners. Role of the N17′ basic group in the interaction with a putative address subsite on the κ opioid receptor.<Emphasis Type="Italic">J Med Chem.</Emphasis> 1994;37:1495–1500.</BibUnstructured>
              </Citation>
              <Citation ID="CR49">
                <CitationNumber>49.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JB</Initials>
                    <FamilyName>Thomas</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SE</Initials>
                    <FamilyName>Fix</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RB</Initials>
                    <FamilyName>Rothman</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Importance of phenolic address groups in opioid kappa receptor selective antagonists</ArticleTitle>
                  <JournalTitle>J Med Chem.</JournalTitle>
                  <VolumeID>47</VolumeID>
                  <FirstPage>1070</FirstPage>
                  <LastPage>1073</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14761209</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXksFOqsQ%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1021/jm030467v</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Thomas JB, Fix SE, Rothman RB, et al., Importance of phenolic address groups in opioid kappa receptor selective antagonists.<Emphasis Type="Italic">J Med Chem.</Emphasis> 2004;47:1070–1073.</BibUnstructured>
              </Citation>
              <Citation ID="CR50">
                <CitationNumber>50.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Marki</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Otvos</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Toth</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Hosztafi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Borsodi</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Tritiated kappa receptor antagonist norbinaltorphimine: synthesis and in vitro binding in three different tissues</ArticleTitle>
                  <JournalTitle>Life Sci.</JournalTitle>
                  <VolumeID>66</VolumeID>
                  <FirstPage>43</FirstPage>
                  <LastPage>49</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10658923</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1MXotFaqtrc%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0024-3205(99)00560-3</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Marki A, Otvos F, Toth G, Hosztafi S, Borsodi A. Tritiated kappa receptor antagonist norbinaltorphimine: synthesis and in vitro binding in three different tissues.<Emphasis Type="Italic">Life Sci.</Emphasis> 2000;66:43–49.</BibUnstructured>
              </Citation>
              <Citation ID="CR51">
                <CitationNumber>51.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SL</Initials>
                    <FamilyName>Olmsted</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AE</Initials>
                    <FamilyName>Takemori</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PS</Initials>
                    <FamilyName>Portoghese</FamilyName>
                  </BibAuthorName>
                  <Year>1993</Year>
                  <ArticleTitle Language="En">A remarkable change of opioid receptor selectivity on the attachment of a peptidomimetic κ address element to the δ antagonist, naltrindole: 5′-[(N<Superscript>2</Superscript>-alkylamidino) methyl]naltrindole derivatives as a novel class of κ opioid receptor antagonists</ArticleTitle>
                  <JournalTitle>J Med Chem.</JournalTitle>
                  <VolumeID>36</VolumeID>
                  <FirstPage>179</FirstPage>
                  <LastPage>180</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8380614</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK3sXpsVWlug%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1021/jm00053a025</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Olmsted SL, Takemori AE, Portoghese PS. A remarkable change of opioid receptor selectivity on the attachment of a peptidomimetic κ address element to the δ antagonist, naltrindole: 5′-[(N<Superscript>2</Superscript>-alkylamidino) methyl]naltrindole derivatives as a novel class of κ opioid receptor antagonists.<Emphasis Type="Italic">J Med Chem.</Emphasis> 1993;36:179–180.</BibUnstructured>
              </Citation>
              <Citation ID="CR52">
                <CitationNumber>52.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>RM</Initials>
                    <FamilyName>Jones</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PS</Initials>
                    <FamilyName>Portoghese</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">5′-Guanidinonaltrindole, a highly selective and potent κ-opioid receptor antagonist</ArticleTitle>
                  <JournalTitle>Eur J Pharmacol.</JournalTitle>
                  <VolumeID>396</VolumeID>
                  <FirstPage>49</FirstPage>
                  <LastPage>52</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10822054</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXjsVGnt70%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0014-2999(00)00208-9</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Jones RM, Portoghese PS. 5′-Guanidinonaltrindole, a highly selective and potent κ-opioid receptor antagonist.<Emphasis Type="Italic">Eur J Pharmacol.</Emphasis> 2000;396:49–52.</BibUnstructured>
              </Citation>
              <Citation ID="CR53">
                <CitationNumber>53.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>AR</Initials>
                    <FamilyName>Jales</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SM</Initials>
                    <FamilyName>Husbands</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JW</Initials>
                    <FamilyName>Lewis</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Selective κ-opioid antagonists related to naltrindole. Effect of side-chain spacer in the 5′-amidinoalkyl series</ArticleTitle>
                  <JournalTitle>Bioorg Med Chem Lett.</JournalTitle>
                  <VolumeID>10</VolumeID>
                  <FirstPage>2259</FirstPage>
                  <LastPage>2261</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11055333</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXntF2lu78%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0960-894X(00)00433-9</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Jales AR, Husbands SM, Lewis JW. Selective κ-opioid antagonists related to naltrindole. Effect of side-chain spacer in the 5′-amidinoalkyl series.<Emphasis Type="Italic">Bioorg Med Chem Lett.</Emphasis> 2000;10:2259–2261.</BibUnstructured>
              </Citation>
              <Citation ID="CR54">
                <CitationNumber>54.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SL</Initials>
                    <FamilyName>Black</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AR</Initials>
                    <FamilyName>Jales</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>W</Initials>
                    <FamilyName>Brandt</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JW</Initials>
                    <FamilyName>Lewis</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SM</Initials>
                    <FamilyName>Husbands</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">The role of the side chain in determining relative δ- and κ-affinity in C5′-substituted analogues of naltrindole</ArticleTitle>
                  <JournalTitle>J Med Chem.</JournalTitle>
                  <VolumeID>46</VolumeID>
                  <FirstPage>314</FirstPage>
                  <LastPage>317</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12519069</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XptlyisLs%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1021/jm020997b</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Black SL, Jales AR, Brandt W, Lewis JW, Husbands SM. The role of the side chain in determining relative δ- and κ-affinity in C5′-substituted analogues of naltrindole.<Emphasis Type="Italic">J Med Chem.</Emphasis> 2003;46:314–317.</BibUnstructured>
              </Citation>
              <Citation ID="CR55">
                <CitationNumber>55.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SL</Initials>
                    <FamilyName>Black</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Chauvignac</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Grundt</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Guanidino N-substituted and N,N-disubstituted derivatives of the κ-opioid antagonist GNTI</ArticleTitle>
                  <JournalTitle>J Med Chem.</JournalTitle>
                  <VolumeID>46</VolumeID>
                  <FirstPage>5505</FirstPage>
                  <LastPage>5511</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14640558</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXovVOisb8%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1021/jm0309203</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Black SL, Chauvignac C, Grundt P, et al. Guanidino N-substituted and N,N-disubstituted derivatives of the κ-opioid antagonist GNTI.<Emphasis Type="Italic">J Med Chem.</Emphasis> 2003;46:5505–5511.</BibUnstructured>
              </Citation>
              <Citation ID="CR56">
                <CitationNumber>56.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Ananthan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HS</Initials>
                    <FamilyName>Kezar</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SK</Initials>
                    <FamilyName>Saini</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Synthesis, opioid receptor binding, and functional activity of 5′-subsitituted 17-cycloprop ylmethylpyrido[2′,3′,:6,7]morphinans</ArticleTitle>
                  <JournalTitle>Bioorg Med Chem Lett.</JournalTitle>
                  <VolumeID>13</VolumeID>
                  <FirstPage>529</FirstPage>
                  <LastPage>532</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12565965</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXptFahtg%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0960-894X(02)00934-4</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Ananthan S, Kezar HS, Saini SK, et al. Synthesis, opioid receptor binding, and functional activity of 5′-subsitituted 17-cycloprop ylmethylpyrido[2′,3′,:6,7]morphinans.<Emphasis Type="Italic">Bioorg Med Chem Lett.</Emphasis> 2003;13:529–532.</BibUnstructured>
              </Citation>
              <Citation ID="CR57">
                <CitationNumber>57.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JB</Initials>
                    <FamilyName>Thomas</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RN</Initials>
                    <FamilyName>Atkinson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RB</Initials>
                    <FamilyName>Rothman</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Identification of the first<Emphasis Type="Italic">trans</Emphasis>-(3R,4R)-dimethyl-4-(3-hydroxyphenyl)piperidine derivative to possess highly potent and selective opioid κ receptor antagonist activity</ArticleTitle>
                  <JournalTitle>J Med Chem.</JournalTitle>
                  <VolumeID>44</VolumeID>
                  <FirstPage>2687</FirstPage>
                  <LastPage>2690</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11495579</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXltFSksbc%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1021/jm015521r</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Thomas JB, Atkinson RN, Rothman RB, et al. Identification of the first<Emphasis Type="Italic">trans</Emphasis>-(3R,4R)-dimethyl-4-(3-hydroxyphenyl)piperidine derivative to possess highly potent and selective opioid κ receptor antagonist activity.<Emphasis Type="Italic">J Med Chem.</Emphasis> 2001;44:2687–2690.</BibUnstructured>
              </Citation>
              <Citation ID="CR58">
                <CitationNumber>58.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>DM</Initials>
                    <FamilyName>Zimmerman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JD</Initials>
                    <FamilyName>Leander</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>BE</Initials>
                    <FamilyName>Cantrell</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1993</Year>
                  <ArticleTitle Language="En">Structure-activity relationships of<Emphasis Type="Italic">trans</Emphasis>-3,4-dimethyl-4-(3-hydroxyphenyl)piperidine antagonists for μ- and κ-opioid receptors</ArticleTitle>
                  <JournalTitle>J Med Chem.</JournalTitle>
                  <VolumeID>36</VolumeID>
                  <FirstPage>2833</FirstPage>
                  <LastPage>2841</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8410998</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK3sXlslemtbc%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1021/jm00072a001</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Zimmerman DM, Leander JD, Cantrell BE, et al. Structure-activity relationships of<Emphasis Type="Italic">trans</Emphasis>-3,4-dimethyl-4-(3-hydroxyphenyl)piperidine antagonists for μ- and κ-opioid receptors.<Emphasis Type="Italic">J Med Chem.</Emphasis> 1993;36:2833–2841.</BibUnstructured>
              </Citation>
              <Citation ID="CR59">
                <CitationNumber>59.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JB</Initials>
                    <FamilyName>Thomas</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MJ</Initials>
                    <FamilyName>Fall</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JB</Initials>
                    <FamilyName>Cooper</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">Identification of an opioid κ receptor subtype-selective N-substituent for (+)-(3R,4R)-dimethyl-4-(3-hydroxyphenyl)piperidine</ArticleTitle>
                  <JournalTitle>J Med Chem.</JournalTitle>
                  <VolumeID>41</VolumeID>
                  <FirstPage>5188</FirstPage>
                  <LastPage>5197</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9857089</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1cXnsV2rtrk%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1021/jm980511k</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Thomas JB, Fall MJ, Cooper JB, et al. Identification of an opioid κ receptor subtype-selective N-substituent for (+)-(3R,4R)-dimethyl-4-(3-hydroxyphenyl)piperidine.<Emphasis Type="Italic">J Med Chem.</Emphasis> 1998;41:5188–5197.</BibUnstructured>
              </Citation>
              <Citation ID="CR60">
                <CitationNumber>60.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JB</Initials>
                    <FamilyName>Thomas</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RN</Initials>
                    <FamilyName>Atkinson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Namdev</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Discovery of an opioid κ receptor selective pure antagonist from a library of N-substituted 4β-methyl-5-(3-hydroxyphenyl)morphans</ArticleTitle>
                  <JournalTitle>J Med Chem.</JournalTitle>
                  <VolumeID>45</VolumeID>
                  <FirstPage>3524</FirstPage>
                  <LastPage>3530</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12139463</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XltV2msb4%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1021/jm020084h</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Thomas JB, Atkinson RN, Namdev N, et al. Discovery of an opioid κ receptor selective pure antagonist from a library of N-substituted 4β-methyl-5-(3-hydroxyphenyl)morphans.<Emphasis Type="Italic">J Med Chem.</Emphasis> 2002;45:3524–3530.</BibUnstructured>
              </Citation>
              <Citation ID="CR61">
                <CitationNumber>61.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Grundt</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>IA</Initials>
                    <FamilyName>Williams</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JW</Initials>
                    <FamilyName>Lewis</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SM</Initials>
                    <FamilyName>Husbands</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Identification of a new scaffold for opioid receptor antagonism based on the 2-amino-1, 1-dimethyl-7-hydroxytetralin pharmacophore</ArticleTitle>
                  <JournalTitle>J Med Chem.</JournalTitle>
                  <VolumeID>47</VolumeID>
                  <FirstPage>5069</FirstPage>
                  <LastPage>5075</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15456250</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXnt12gtrY%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1021/jm040807s</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Grundt P, Williams IA, Lewis JW, Husbands SM. Identification of a new scaffold for opioid receptor antagonism based on the 2-amino-1, 1-dimethyl-7-hydroxytetralin pharmacophore.<Emphasis Type="Italic">J Med Chem.</Emphasis> 2004;47:5069–5075.</BibUnstructured>
              </Citation>
              <Citation ID="CR62">
                <CitationNumber>62.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>BR</Initials>
                    <FamilyName>Costa</FamilyName>
                    <Particle>de</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Band</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RB</Initials>
                    <FamilyName>Rothman</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1989</Year>
                  <ArticleTitle Language="En">Synthesis of an affinity ligand (‘UPHIT’) for in vivo acylation of the κ-opioid receptor</ArticleTitle>
                  <JournalTitle>FEBS Lett.</JournalTitle>
                  <VolumeID>249</VolumeID>
                  <FirstPage>178</FirstPage>
                  <LastPage>182</LastPage>
                  <Occurrence Type="PID">
                    <Handle>2544446</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/0014-5793(89)80619-2</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>de Costa BR, Band L, Rothman RB, et al. Synthesis of an affinity ligand (‘UPHIT’) for in vivo acylation of the κ-opioid receptor.<Emphasis Type="Italic">FEBS Lett.</Emphasis> 1989;249:178–182.</BibUnstructured>
              </Citation>
              <Citation ID="CR63">
                <CitationNumber>63.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>BR</Initials>
                    <FamilyName>Costa</FamilyName>
                    <Particle>de</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RB</Initials>
                    <FamilyName>Rothman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Bykov</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AE</Initials>
                    <FamilyName>Jacobson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KC</Initials>
                    <FamilyName>Rice</FamilyName>
                  </BibAuthorName>
                  <Year>1989</Year>
                  <ArticleTitle Language="En">Selective and enantiospecific acylation of κ opioid receptors by (1S,2S)-<Emphasis Type="Italic">trans</Emphasis>-2-isothiocyanato-<Emphasis Type="Italic">N</Emphasis>-methyl-<Emphasis Type="Italic">N</Emphasis>-[2-(1-pyrrolidinyl)cyclohecyl]benze neacetamide. Demonstration of κ receptor heterogeneity</ArticleTitle>
                  <JournalTitle>J Med Chem.</JournalTitle>
                  <VolumeID>32</VolumeID>
                  <FirstPage>281</FirstPage>
                  <LastPage>283</LastPage>
                  <Occurrence Type="PID">
                    <Handle>2536435</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1021/jm00122a001</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>de Costa BR, Rothman RB, Bykov V, Jacobson AE, Rice KC. Selective and enantiospecific acylation of κ opioid receptors by (1S,2S)-<Emphasis Type="Italic">trans</Emphasis>-2-isothiocyanato-<Emphasis Type="Italic">N</Emphasis>-methyl-<Emphasis Type="Italic">N</Emphasis>-[2-(1-pyrrolidinyl)cyclohecyl]benze neacetamide. Demonstration of κ receptor heterogeneity.<Emphasis Type="Italic">J Med Chem.</Emphasis> 1989;32:281–283.</BibUnstructured>
              </Citation>
              <Citation ID="CR64">
                <CitationNumber>64.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>AC</Initials>
                    <FamilyName>Chang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AE</Initials>
                    <FamilyName>Takemori</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PS</Initials>
                    <FamilyName>Portoghese</FamilyName>
                  </BibAuthorName>
                  <Year>1994</Year>
                  <ArticleTitle Language="En">2-(3,4-dichlorophenyl)-<Emphasis Type="Italic">N</Emphasis>-methyl-<Emphasis Type="Italic">N</Emphasis>-[(1<Emphasis Type="Italic">S</Emphasis>)-1-(3-isothiocyanatophenyl)-2-(1-pyrrolidinyl)ethyl]acet amide: an opioid receptor affinity label that produces selective and long-lasting κ antagonism in mice</ArticleTitle>
                  <JournalTitle>J Med Chem.</JournalTitle>
                  <VolumeID>37</VolumeID>
                  <FirstPage>1547</FirstPage>
                  <LastPage>1549</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8201586</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2cXktV2jtbg%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1021/jm00037a001</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Chang AC, Takemori AE, Portoghese PS. 2-(3,4-dichlorophenyl)-<Emphasis Type="Italic">N</Emphasis>-methyl-<Emphasis Type="Italic">N</Emphasis>-[(1<Emphasis Type="Italic">S</Emphasis>)-1-(3-isothiocyanatophenyl)-2-(1-pyrrolidinyl)ethyl]acet amide: an opioid receptor affinity label that produces selective and long-lasting κ antagonism in mice.<Emphasis Type="Italic">J Med Chem.</Emphasis> 1994;37:1547–1549.</BibUnstructured>
              </Citation>
              <Citation ID="CR65">
                <CitationNumber>65.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>AC</Initials>
                    <FamilyName>Chang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AE</Initials>
                    <FamilyName>Takemori</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>WH</Initials>
                    <FamilyName>Ojala</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>WB</Initials>
                    <FamilyName>Gleason</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PS</Initials>
                    <FamilyName>Portoghese</FamilyName>
                  </BibAuthorName>
                  <Year>1994</Year>
                  <ArticleTitle Language="En">κ opioid receptor selective affinity labels: electrophilic benzeneacetamides as κ-selective opioid antagonists</ArticleTitle>
                  <JournalTitle>J Med Chem.</JournalTitle>
                  <VolumeID>37</VolumeID>
                  <FirstPage>1547</FirstPage>
                  <LastPage>1549</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8201586</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2cXktV2jtbg%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1021/jm00037a001</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Chang AC, Takemori AE, Ojala WH, Gleason WB, Portoghese PS. κ opioid receptor selective affinity labels: electrophilic benzeneacetamides as κ-selective opioid antagonists.<Emphasis Type="Italic">J Med Chem.</Emphasis> 1994;37:1547–1549.</BibUnstructured>
              </Citation>
              <Citation ID="CR66">
                <CitationNumber>66.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Chauvignac</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CN</Initials>
                    <FamilyName>Miller</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SK</Initials>
                    <FamilyName>Srivastava</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JW</Initials>
                    <FamilyName>Lewis</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SM</Initials>
                    <FamilyName>Husbands</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JR</Initials>
                    <FamilyName>Taynor</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">Major effect of pyrrolic N-benzylation in norbinaltorphiminie, the selective κ-opioid receptor antagonist</ArticleTitle>
                  <JournalTitle>J Med Chem.</JournalTitle>
                  <VolumeID>48</VolumeID>
                  <FirstPage>1676</FirstPage>
                  <LastPage>1679</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15743210</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2MXht1Oru78%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1021/jm049172n</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Chauvignac C, Miller CN, Srivastava SK, Lewis JW, Husbands SM, Taynor JR. Major effect of pyrrolic N-benzylation in norbinaltorphiminie, the selective κ-opioid receptor antagonist.<Emphasis Type="Italic">J Med Chem.</Emphasis> 2005;48:1676–1679.</BibUnstructured>
              </Citation>
              <Citation ID="CR67">
                <CitationNumber>67.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SS</Initials>
                    <FamilyName>Negus</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>NK</Initials>
                    <FamilyName>Mello</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DC</Initials>
                    <FamilyName>Linsenmayer</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RM</Initials>
                    <FamilyName>Jones</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PS</Initials>
                    <FamilyName>Portoghese</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Kappa opioid antagonist effects of the novel kappa antagonist 5′-guanidinonaltrindole (GNTI) in an assay of schedule-controlled behavior in rhesus monkeys</ArticleTitle>
                  <JournalTitle>Psychopharmacology (Berlin)</JournalTitle>
                  <VolumeID>163</VolumeID>
                  <FirstPage>412</FirstPage>
                  <LastPage>419</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XnsFymu7o%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1007/s00213-002-1038-x</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Negus SS, Mello NK, Linsenmayer DC, Jones RM, Portoghese PS. Kappa opioid antagonist effects of the novel kappa antagonist 5′-guanidinonaltrindole (GNTI) in an assay of schedule-controlled behavior in rhesus monkeys.<Emphasis Type="Italic">Psychopharmacology (Berlin)</Emphasis>. 2002;163:412–419.</BibUnstructured>
              </Citation>
              <Citation ID="CR68">
                <CitationNumber>68.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>AJ</Initials>
                    <FamilyName>Bertalmio</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JH</Initials>
                    <FamilyName>Woods</FamilyName>
                  </BibAuthorName>
                  <Year>1987</Year>
                  <ArticleTitle Language="En">Differentiation between<Emphasis Type="Italic">mu</Emphasis> and<Emphasis Type="Italic">kappa</Emphasis> receptor-mediated effects in opioid drug discrimination: apparent pA<Subscript>2</Subscript> analysis</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther.</JournalTitle>
                  <VolumeID>243</VolumeID>
                  <FirstPage>591</FirstPage>
                  <LastPage>597</LastPage>
                  <Occurrence Type="PID">
                    <Handle>2824753</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaL1cXjtFylsQ%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Bertalmio AJ, Woods JH. Differentiation between<Emphasis Type="Italic">mu</Emphasis> and<Emphasis Type="Italic">kappa</Emphasis> receptor-mediated effects in opioid drug discrimination: apparent pA<Subscript>2</Subscript> analysis.<Emphasis Type="Italic">J Pharmacol Exp Ther.</Emphasis> 1987;243:591–597.</BibUnstructured>
              </Citation>
              <Citation ID="CR69">
                <CitationNumber>69.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SS</Initials>
                    <FamilyName>Negus</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>ER</Initials>
                    <FamilyName>Butelman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KJ</Initials>
                    <FamilyName>Chang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>DeCosta</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Winger</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JH</Initials>
                    <FamilyName>Woods</FamilyName>
                  </BibAuthorName>
                  <Year>1994</Year>
                  <ArticleTitle Language="En">Behavioral effects of the systemically active<Emphasis Type="Italic">delta</Emphasis> opioid agonist BW373U86 in rhesus monkeys</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther.</JournalTitle>
                  <VolumeID>270</VolumeID>
                  <FirstPage>1025</FirstPage>
                  <LastPage>1034</LastPage>
                  <Occurrence Type="PID">
                    <Handle>7932149</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2cXmslWqtLk%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Negus SS, Butelman ER, Chang KJ, DeCosta B, Winger G, Woods JH. Behavioral effects of the systemically active<Emphasis Type="Italic">delta</Emphasis> opioid agonist BW373U86 in rhesus monkeys.<Emphasis Type="Italic">J Pharmacol Exp Ther.</Emphasis> 1994;270:1025–1034.</BibUnstructured>
              </Citation>
              <Citation ID="CR70">
                <CitationNumber>70.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>I</Initials>
                    <FamilyName>Carroll</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JB</Initials>
                    <FamilyName>Thomas</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LA</Initials>
                    <FamilyName>Dykstra</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Pharmacological properties of JDTic: a novel κ-opioid receptor antagonist</ArticleTitle>
                  <JournalTitle>Eur J Pharmacol.</JournalTitle>
                  <VolumeID>501</VolumeID>
                  <FirstPage>111</FirstPage>
                  <LastPage>119</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15464069</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXotFClt7s%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.ejphar.2004.08.028</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Carroll I, Thomas JB, Dykstra LA, et al. Pharmacological properties of JDTic: a novel κ-opioid receptor antagonist.<Emphasis Type="Italic">Eur J Pharmacol.</Emphasis> 2004;501:111–119.</BibUnstructured>
              </Citation>
              <Citation ID="CR71">
                <CitationNumber>71.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>ER</Initials>
                    <FamilyName>Butelman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SS</Initials>
                    <FamilyName>Negus</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Ai</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>BR</Initials>
                    <FamilyName>deCosta</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JH</Initials>
                    <FamilyName>Woods</FamilyName>
                  </BibAuthorName>
                  <Year>1993</Year>
                  <ArticleTitle Language="En">Kappa opioid antagonist effects of systemically administered norbinaltorphimine in a thermal antinociception assay in rhesus monkeys</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther.</JournalTitle>
                  <VolumeID>267</VolumeID>
                  <FirstPage>1269</FirstPage>
                  <LastPage>1276</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8263790</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2cXmvFCqsA%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Butelman ER, Negus SS, Ai Y, deCosta BR, Woods JH. Kappa opioid antagonist effects of systemically administered norbinaltorphimine in a thermal antinociception assay in rhesus monkeys.<Emphasis Type="Italic">J Pharmacol Exp Ther.</Emphasis> 1993;267:1269–1276.</BibUnstructured>
              </Citation>
              <Citation ID="CR72">
                <CitationNumber>72.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Endoh</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Matsuura</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Tanaka</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Nagase</FamilyName>
                  </BibAuthorName>
                  <Year>1992</Year>
                  <ArticleTitle Language="En">Nor-binaltorphimine: a potent and selective kappa-opioid receptor antagonist with long-lasting activity in vivo</ArticleTitle>
                  <JournalTitle>Arch Int Pharmacodyn Ther.</JournalTitle>
                  <VolumeID>316</VolumeID>
                  <FirstPage>30</FirstPage>
                  <LastPage>42</LastPage>
                  <Occurrence Type="PID">
                    <Handle>1326932</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK38XlsVegsrk%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Endoh T, Matsuura H, Tanaka C, Nagase H. Nor-binaltorphimine: a potent and selective kappa-opioid receptor antagonist with long-lasting activity in vivo.<Emphasis Type="Italic">Arch Int Pharmacodyn Ther.</Emphasis> 1992;316:30–42.</BibUnstructured>
              </Citation>
              <Citation ID="CR73">
                <CitationNumber>73.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JH</Initials>
                    <FamilyName>Broadbear</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SS</Initials>
                    <FamilyName>Negus</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>ER</Initials>
                    <FamilyName>Butelman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>BR</Initials>
                    <FamilyName>Costa</FamilyName>
                    <Particle>de</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JH</Initials>
                    <FamilyName>Woods</FamilyName>
                  </BibAuthorName>
                  <Year>1994</Year>
                  <ArticleTitle Language="En">Differential effects of systemically administered nor-binaltorphimine (nor-BNI) on kappa-opioid agonists in the mouse writhing assay</ArticleTitle>
                  <JournalTitle>Psychopharmacology (Berlin)</JournalTitle>
                  <VolumeID>115</VolumeID>
                  <FirstPage>311</FirstPage>
                  <LastPage>319</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2cXlsVyqtb4%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1007/BF02245071</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Broadbear JH, Negus SS, Butelman ER, de Costa BR, Woods JH. Differential effects of systemically administered nor-binaltorphimine (nor-BNI) on kappa-opioid agonists in the mouse writhing assay.<Emphasis Type="Italic">Psychopharmacology (Berlin)</Emphasis>. 1994;115:311–319.</BibUnstructured>
              </Citation>
              <Citation ID="CR74">
                <CitationNumber>74.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>MCH</Initials>
                    <FamilyName>Ko</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Lee</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MS</Initials>
                    <FamilyName>Song</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Activation of κ-opioid receptors inhibits pruritus evoked by subcutaneous or intrathecal administration of morphine in monkeys</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther.</JournalTitle>
                  <VolumeID>305</VolumeID>
                  <FirstPage>173</FirstPage>
                  <LastPage>179</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12649366</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXis1anurw%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1124/jpet.102.044909</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Ko MCH, Lee H, Song MS, et al. Activation of κ-opioid receptors inhibits pruritus evoked by subcutaneous or intrathecal administration of morphine in monkeys.<Emphasis Type="Italic">J Pharmacol Exp Ther.</Emphasis> 2003;305:173–179.</BibUnstructured>
              </Citation>
              <Citation ID="CR75">
                <CitationNumber>75.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>DNC</Initials>
                    <FamilyName>Jones</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SG</Initials>
                    <FamilyName>Holtzman</FamilyName>
                  </BibAuthorName>
                  <Year>1992</Year>
                  <ArticleTitle Language="En">Long term kappa opioid receptor blockade following nor-binaltorphimine</ArticleTitle>
                  <JournalTitle>Eur J Pharmacol.</JournalTitle>
                  <VolumeID>215</VolumeID>
                  <FirstPage>345</FirstPage>
                  <LastPage>348</LastPage>
                  <Occurrence Type="PID">
                    <Handle>1327807</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK38XksVSgsrc%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/0014-2999(92)90055-9</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Jones DNC, Holtzman SG. Long term kappa opioid receptor blockade following nor-binaltorphimine.<Emphasis Type="Italic">Eur J Pharmacol.</Emphasis> 1992;215:345–348.</BibUnstructured>
              </Citation>
              <Citation ID="CR76">
                <CitationNumber>76.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Horan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Taylor</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HI</Initials>
                    <FamilyName>Yamamura</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Porreca</FamilyName>
                  </BibAuthorName>
                  <Year>1992</Year>
                  <ArticleTitle Language="En">Extremely long-lasting antagonistic actions of nor-binaltorphimine (nor-BNI) in the mouse tail-flick test</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther.</JournalTitle>
                  <VolumeID>260</VolumeID>
                  <FirstPage>1237</FirstPage>
                  <LastPage>1243</LastPage>
                  <Occurrence Type="PID">
                    <Handle>1312164</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK38XitVOltLk%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Horan P, Taylor J, Yamamura HI, Porreca F. Extremely long-lasting antagonistic actions of nor-binaltorphimine (nor-BNI) in the mouse tail-flick test.<Emphasis Type="Italic">J Pharmacol Exp Ther.</Emphasis> 1992;260:1237–1243.</BibUnstructured>
              </Citation>
              <Citation ID="CR77">
                <CitationNumber>77.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>MCH</Initials>
                    <FamilyName>Ko</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MD</Initials>
                    <FamilyName>Johnson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>ER</Initials>
                    <FamilyName>Butelman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KJ</Initials>
                    <FamilyName>Willmont</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HI</Initials>
                    <FamilyName>Mosberg</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JH</Initials>
                    <FamilyName>Woods</FamilyName>
                  </BibAuthorName>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">Intracisternal nor-binaltorphimine distinguishes central and peripheral kappa-opioid antinociception in rhesus monkeys</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther.</JournalTitle>
                  <VolumeID>291</VolumeID>
                  <FirstPage>1113</FirstPage>
                  <LastPage>1120</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10565831</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1MXnslygu7w%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Ko MCH, Johnson MD, Butelman ER, Willmont KJ, Mosberg HI, Woods JH. Intracisternal nor-binaltorphimine distinguishes central and peripheral kappa-opioid antinociception in rhesus monkeys.<Emphasis Type="Italic">J Pharmacol Exp Ther.</Emphasis> 1999;291:1113–1120.</BibUnstructured>
              </Citation>
              <Citation ID="CR78">
                <CitationNumber>78.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>DC</Initials>
                    <FamilyName>Jewett</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JH</Initials>
                    <FamilyName>Woods</FamilyName>
                  </BibAuthorName>
                  <Year>1995</Year>
                  <ArticleTitle Language="En">Nor-binaltorphimine: a very, very long acting kappa opioid antagonist in pigeons</ArticleTitle>
                  <JournalTitle>Behav Pharmacol.</JournalTitle>
                  <VolumeID>6</VolumeID>
                  <FirstPage>815</FirstPage>
                  <LastPage>820</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11224385</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK28XhtVSgtb0%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Jewett DC, Woods JH. Nor-binaltorphimine: a very, very long acting kappa opioid antagonist in pigeons.<Emphasis Type="Italic">Behav Pharmacol.</Emphasis> 1995;6:815–820.</BibUnstructured>
              </Citation>
              <Citation ID="CR79">
                <CitationNumber>79.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>AE</Initials>
                    <FamilyName>Takemori</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>BY</Initials>
                    <FamilyName>Ho</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JS</Initials>
                    <FamilyName>Naeseth</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PS</Initials>
                    <FamilyName>Portoghese</FamilyName>
                  </BibAuthorName>
                  <Year>1988</Year>
                  <ArticleTitle Language="En">Norbinaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther.</JournalTitle>
                  <VolumeID>246</VolumeID>
                  <FirstPage>255</FirstPage>
                  <LastPage>258</LastPage>
                  <Occurrence Type="PID">
                    <Handle>2839664</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaL1cXkvVKmurg%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Takemori AE, Ho BY, Naeseth JS, Portoghese PS. Norbinaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays.<Emphasis Type="Italic">J Pharmacol Exp Ther.</Emphasis> 1988;246:255–258.</BibUnstructured>
              </Citation>
              <Citation ID="CR80">
                <CitationNumber>80.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>AE</Initials>
                    <FamilyName>Takemori</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MM</Initials>
                    <FamilyName>Schwartz</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PS</Initials>
                    <FamilyName>Portoghese</FamilyName>
                  </BibAuthorName>
                  <Year>1988</Year>
                  <ArticleTitle Language="En">Suppression by norbinaltorphimine of<Emphasis Type="Italic">kappa</Emphasis> opioid-mediated diuresis in rats</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther.</JournalTitle>
                  <VolumeID>247</VolumeID>
                  <FirstPage>971</FirstPage>
                  <LastPage>974</LastPage>
                  <Occurrence Type="PID">
                    <Handle>2849679</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaL1MXhtVOqu78%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Takemori AE, Schwartz MM, Portoghese PS. Suppression by norbinaltorphimine of<Emphasis Type="Italic">kappa</Emphasis> opioid-mediated diuresis in rats.<Emphasis Type="Italic">J Pharmacol Exp Ther.</Emphasis> 1988;247:971–974.</BibUnstructured>
              </Citation>
              <Citation ID="CR81">
                <CitationNumber>81.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>MCH</Initials>
                    <FamilyName>Ko</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KJ</Initials>
                    <FamilyName>Willmont</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Lee</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>GS</Initials>
                    <FamilyName>Flory</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JH</Initials>
                    <FamilyName>Woods</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Ultra-long antagonism of kappa opioid agonist-induced diuresis by intracisternal nor-binaltorphimine in monkeys</ArticleTitle>
                  <JournalTitle>Brain Res.</JournalTitle>
                  <VolumeID>982</VolumeID>
                  <FirstPage>38</FirstPage>
                  <LastPage>44</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12915238</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXmt1aiu7g%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0006-8993(03)02938-X</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Ko MCH, Willmont KJ, Lee H, Flory GS, Woods JH. Ultra-long antagonism of kappa opioid agonist-induced diuresis by intracisternal nor-binaltorphimine in monkeys.<Emphasis Type="Italic">Brain Res.</Emphasis> 2003;982:38–44.</BibUnstructured>
              </Citation>
              <Citation ID="CR82">
                <CitationNumber>82.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>WA</Initials>
                    <FamilyName>Carlezon</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Thome</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>VG</Initials>
                    <FamilyName>Olson</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">Regulation of cocaine reward by CREB</ArticleTitle>
                  <JournalTitle>Science</JournalTitle>
                  <VolumeID>282</VolumeID>
                  <FirstPage>2272</FirstPage>
                  <LastPage>2275</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9856954</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1cXotFGjt7o%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1126/science.282.5397.2272</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Carlezon WA Jr, Thome J, Olson VG, et al. Regulation of cocaine reward by CREB.<Emphasis Type="Italic">Science</Emphasis>. 1998;282:2272–2275.</BibUnstructured>
              </Citation>
              <Citation ID="CR83">
                <CitationNumber>83.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>AM</Initials>
                    <FamilyName>Pliakas</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RR</Initials>
                    <FamilyName>Carlson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RL</Initials>
                    <FamilyName>Neve</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Konradi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>EJ</Initials>
                    <FamilyName>Nestler</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>WA</Initials>
                    <FamilyName>Carlexon</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated cAMP response element-binding protein expression in nucleus accum bens</ArticleTitle>
                  <JournalTitle>J Neurosci.</JournalTitle>
                  <VolumeID>21</VolumeID>
                  <FirstPage>7397</FirstPage>
                  <LastPage>7403</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11549750</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXmvFWgsro%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Pliakas AM, Carlson RR, Neve RL, Konradi C, Nestler EJ, Carlexon WA. Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated cAMP response element-binding protein expression in nucleus accum bens.<Emphasis Type="Italic">J Neurosci.</Emphasis> 2001;21:7397–7403.</BibUnstructured>
              </Citation>
              <Citation ID="CR84">
                <CitationNumber>84.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JP</Initials>
                    <FamilyName>McLaughlin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Marton-Popovici</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Chavkin</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">κ opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses</ArticleTitle>
                  <JournalTitle>J Neurosci.</JournalTitle>
                  <VolumeID>23</VolumeID>
                  <FirstPage>5674</FirstPage>
                  <LastPage>5683</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12843270</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXltl2qsbo%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>McLaughlin JP, Marton-Popovici M, Chavkin C. κ opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses.<Emphasis Type="Italic">J Neurosci.</Emphasis> 2003;23:5674–5683.</BibUnstructured>
              </Citation>
              <Citation ID="CR85">
                <CitationNumber>85.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Berrocoso</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MO</Initials>
                    <FamilyName>Rojas-Corrales</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JA</Initials>
                    <FamilyName>Mico</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Non-selective opioid receptor antagonism of the antidepressant-like effect of venlafaxine in the forced swimming test in mice</ArticleTitle>
                  <JournalTitle>Neurosci Lett.</JournalTitle>
                  <VolumeID>363</VolumeID>
                  <FirstPage>25</FirstPage>
                  <LastPage>28</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15157989</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXkt1Slsbs%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.neulet.2004.03.041</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Berrocoso E, Rojas-Corrales MO, Mico JA. Non-selective opioid receptor antagonism of the antidepressant-like effect of venlafaxine in the forced swimming test in mice.<Emphasis Type="Italic">Neurosci Lett.</Emphasis> 2004;363:25–28.</BibUnstructured>
              </Citation>
              <Citation ID="CR86">
                <CitationNumber>86.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SS</Initials>
                    <FamilyName>Newton</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Thome</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TL</Initials>
                    <FamilyName>Wallace</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Inhibition of cAMP response element-binding protein or dynorphin in the nucleus accum bens produces an antidepressant-like effect</ArticleTitle>
                  <JournalTitle>J Neurosci.</JournalTitle>
                  <VolumeID>22</VolumeID>
                  <FirstPage>10883</FirstPage>
                  <LastPage>10890</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12486182</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XpslCqtL4%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Newton SS, Thome J, Wallace TL, et al. Inhibition of cAMP response element-binding protein or dynorphin in the nucleus accum bens produces an antidepressant-like effect.<Emphasis Type="Italic">J Neurosci.</Emphasis> 2002;22:10883–10890.</BibUnstructured>
              </Citation>
              <Citation ID="CR87">
                <CitationNumber>87.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Shirayama</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Ishida</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Iwata</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Hazama</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Kawahara</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RS</Initials>
                    <FamilyName>Duman</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Stress increases dynorphin immunoreactivity in limbic brain regions and dynorphin antagonism produces antidepressant-like effects</ArticleTitle>
                  <JournalTitle>J Neurochem.</JournalTitle>
                  <VolumeID>90</VolumeID>
                  <FirstPage>1258</FirstPage>
                  <LastPage>1268</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15312181</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXns1Sqs78%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1111/j.1471-4159.2004.02589.x</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Shirayama Y, Ishida H, Iwata M, Hazama G, Kawahara R, Duman RS. Stress increases dynorphin immunoreactivity in limbic brain regions and dynorphin antagonism produces antidepressant-like effects.<Emphasis Type="Italic">J Neurochem.</Emphasis> 2004;90:1258–1268.</BibUnstructured>
              </Citation>
              <Citation ID="CR88">
                <CitationNumber>88.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Kamei</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Nagase</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Norbinaltorphimine, a selective κ opioid receptor antagonist, induces an itch-associated response in mice</ArticleTitle>
                  <JournalTitle>Eur J Pharmacol.</JournalTitle>
                  <VolumeID>418</VolumeID>
                  <FirstPage>141</FirstPage>
                  <LastPage>145</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11334876</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXjtFGntbk%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0014-2999(01)00941-4</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Kamei J, Nagase H. Norbinaltorphimine, a selective κ opioid receptor antagonist, induces an itch-associated response in mice.<Emphasis Type="Italic">Eur J Pharmacol.</Emphasis> 2001;418:141–145.</BibUnstructured>
              </Citation>
              <Citation ID="CR89">
                <CitationNumber>89.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Cowan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Inan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>GB</Initials>
                    <FamilyName>Kehner</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">GNTI, a kappa receptor antagonist, causes compulsive scratching in mice</ArticleTitle>
                  <JournalTitle>The Pharmacologist.</JournalTitle>
                  <VolumeID>44</VolumeID>
                  <FirstPage>A51</FirstPage>
                  <LastPage>A51</LastPage>
                </BibArticle>
                <BibUnstructured>Cowan A, Inan S, Kehner GB. GNTI, a kappa receptor antagonist, causes compulsive scratching in mice.<Emphasis Type="Italic">The Pharmacologist.</Emphasis> 2002;44:A51.</BibUnstructured>
              </Citation>
              <Citation ID="CR90">
                <CitationNumber>90.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Togashi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Umeuchi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Okano</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Antipruritic activity of the κ-opioid receptor agonist, TRK-820</ArticleTitle>
                  <JournalTitle>Eur J Pharmacol.</JournalTitle>
                  <VolumeID>435</VolumeID>
                  <FirstPage>259</FirstPage>
                  <LastPage>264</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11821035</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XovFGhsw%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0014-2999(01)01588-6</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Togashi Y, Umeuchi H, Okano K, et al. Antipruritic activity of the κ-opioid receptor agonist, TRK-820.<Emphasis Type="Italic">Eur J Pharmacol.</Emphasis> 2002;435:259–264.</BibUnstructured>
              </Citation>
              <Citation ID="CR91">
                <CitationNumber>91.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>MCH</Initials>
                    <FamilyName>Ko</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Lee</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MS</Initials>
                    <FamilyName>Song</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Activation of κ-opioid receptors inhibits pruritus evoked by subcutaneous of intrathecal administration of morphine in monkeys</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther.</JournalTitle>
                  <VolumeID>305</VolumeID>
                  <FirstPage>173</FirstPage>
                  <LastPage>179</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12649366</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXis1anurw%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1124/jpet.102.044909</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Ko MCH, Lee H, Song MS, et al. Activation of κ-opioid receptors inhibits pruritus evoked by subcutaneous of intrathecal administration of morphine in monkeys.<Emphasis Type="Italic">J Pharmacol Exp Ther.</Emphasis> 2003;305:173–179.</BibUnstructured>
              </Citation>
              <Citation ID="CR92">
                <CitationNumber>92.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Umeuchi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Togashi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Honda</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Involvement of central μ-opioid system in the scratching behavior in mice, and the suppression of it by the activation of κ-opioid system</ArticleTitle>
                  <JournalTitle>Eur J Pharmacol.</JournalTitle>
                  <VolumeID>477</VolumeID>
                  <FirstPage>29</FirstPage>
                  <LastPage>35</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14512095</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXnsVamtrk%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.ejphar.2003.08.007</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Umeuchi H, Togashi Y, Honda T, et al. Involvement of central μ-opioid system in the scratching behavior in mice, and the suppression of it by the activation of κ-opioid system.<Emphasis Type="Italic">Eur J Pharmacol.</Emphasis> 2003;477:29–35.</BibUnstructured>
              </Citation>
              <Citation ID="CR93">
                <CitationNumber>93.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>AS</Initials>
                    <FamilyName>Levine</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Grace</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PS</Initials>
                    <FamilyName>Portoghese</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CJ</Initials>
                    <FamilyName>Billington</FamilyName>
                  </BibAuthorName>
                  <Year>1994</Year>
                  <ArticleTitle Language="En">The effect of selective opioid antagonists on butorphanol-induced feeding</ArticleTitle>
                  <JournalTitle>Brain Res.</JournalTitle>
                  <VolumeID>637</VolumeID>
                  <FirstPage>242</FirstPage>
                  <LastPage>248</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8180802</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2cXitVygtbs%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/0006-8993(94)91239-4</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Levine AS, Grace M, Portoghese PS, Billington CJ. The effect of selective opioid antagonists on butorphanol-induced feeding.<Emphasis Type="Italic">Brain Res.</Emphasis> 1994;637:242–248.</BibUnstructured>
              </Citation>
              <Citation ID="CR94">
                <CitationNumber>94.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JL</Initials>
                    <FamilyName>Cole</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Berman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RJ</Initials>
                    <FamilyName>Bodnar</FamilyName>
                  </BibAuthorName>
                  <Year>1997</Year>
                  <ArticleTitle Language="En">Evaluation of chronic opioid receptor antagonist effects upon weight and intake measures in lean and obese zucker rats</ArticleTitle>
                  <JournalTitle>Peptides</JournalTitle>
                  <VolumeID>18</VolumeID>
                  <FirstPage>1201</FirstPage>
                  <LastPage>1207</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9396062</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2sXntlersbc%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0196-9781(97)00074-0</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Cole JL, Berman N, Bodnar RJ. Evaluation of chronic opioid receptor antagonist effects upon weight and intake measures in lean and obese zucker rats.<Emphasis Type="Italic">Peptides</Emphasis>. 1997;18:1201–1207.</BibUnstructured>
              </Citation>
              <Citation ID="CR95">
                <CitationNumber>95.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>RJ</Initials>
                    <FamilyName>Bodnar</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MJ</Initials>
                    <FamilyName>Glass</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Ragnauth</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>ML</Initials>
                    <FamilyName>Cooper</FamilyName>
                  </BibAuthorName>
                  <Year>1995</Year>
                  <ArticleTitle Language="En">General, μ and κ opioid antagonists in the nucleus accum bens alter food intake under deprivation, glucoprivic and palatable conditions</ArticleTitle>
                  <JournalTitle>Brain Res.</JournalTitle>
                  <VolumeID>700</VolumeID>
                  <FirstPage>205</FirstPage>
                  <LastPage>212</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8624711</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2MXpvVyktLc%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/0006-8993(95)00957-R</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Bodnar RJ, Glass MJ, Ragnauth A, Cooper ML. General, μ and κ opioid antagonists in the nucleus accum bens alter food intake under deprivation, glucoprivic and palatable conditions.<Emphasis Type="Italic">Brain Res.</Emphasis> 1995;700:205–212.</BibUnstructured>
              </Citation>
              <Citation ID="CR96">
                <CitationNumber>96.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Leventhal</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TC</Initials>
                    <FamilyName>Kirkham</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JL</Initials>
                    <FamilyName>Cole</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RJ</Initials>
                    <FamilyName>Bodnar</FamilyName>
                  </BibAuthorName>
                  <Year>1995</Year>
                  <ArticleTitle Language="En">Selective actions of central μ and κ opioid antagonists upon sucrose intake in sham-fed rats</ArticleTitle>
                  <JournalTitle>Brain Res.</JournalTitle>
                  <VolumeID>685</VolumeID>
                  <FirstPage>205</FirstPage>
                  <LastPage>210</LastPage>
                  <Occurrence Type="PID">
                    <Handle>7583248</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2MXntFCksrk%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/0006-8993(95)00385-4</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Leventhal L, Kirkham TC, Cole JL, Bodnar RJ. Selective actions of central μ and κ opioid antagonists upon sucrose intake in sham-fed rats.<Emphasis Type="Italic">Brain Res.</Emphasis> 1995;685:205–210.</BibUnstructured>
              </Citation>
              <Citation ID="CR97">
                <CitationNumber>97.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Khaimova</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Kandov</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Israel</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Cataldo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MM</Initials>
                    <FamilyName>Hadjimarkou</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RJ</Initials>
                    <FamilyName>Bodnar</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Opioid receptor subtype antagonists differentially alter GABA agonist-induced feeding elicited from either the nucleus accumbens shell or ventral tegmental area regions in rats</ArticleTitle>
                  <JournalTitle>Brain Res.</JournalTitle>
                  <VolumeID>1026</VolumeID>
                  <FirstPage>284</FirstPage>
                  <LastPage>294</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15488491</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXos1ehtbk%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.brainres.2004.08.032</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Khaimova E, Kandov Y, Israel Y, Cataldo G, Hadjimarkou MM, Bodnar RJ. Opioid receptor subtype antagonists differentially alter GABA agonist-induced feeding elicited from either the nucleus accumbens shell or ventral tegmental area regions in rats.<Emphasis Type="Italic">Brain Res.</Emphasis> 2004;1026:284–294.</BibUnstructured>
              </Citation>
              <Citation ID="CR98">
                <CitationNumber>98.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>CM</Initials>
                    <FamilyName>Kotz</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MK</Initials>
                    <FamilyName>Grace</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CJ</Initials>
                    <FamilyName>Billington</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AS</Initials>
                    <FamilyName>Levine</FamilyName>
                  </BibAuthorName>
                  <Year>1993</Year>
                  <ArticleTitle Language="En">The effect of norbinaltorphimine, β-funaltrexamine and naltrindole on NPY-induced feeding</ArticleTitle>
                  <JournalTitle>Brain Res.</JournalTitle>
                  <VolumeID>631</VolumeID>
                  <FirstPage>325</FirstPage>
                  <LastPage>328</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8131061</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2cXps1Kjtw%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/0006-8993(93)91552-4</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Kotz CM, Grace MK, Billington CJ, Levine AS. The effect of norbinaltorphimine, β-funaltrexamine and naltrindole on NPY-induced feeding.<Emphasis Type="Italic">Brain Res.</Emphasis> 1993;631:325–328.</BibUnstructured>
              </Citation>
              <Citation ID="CR99">
                <CitationNumber>99.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>DJ</Initials>
                    <FamilyName>Calcagnetti</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RL</Initials>
                    <FamilyName>Calcagnetti</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MS</Initials>
                    <FamilyName>Fanselow</FamilyName>
                  </BibAuthorName>
                  <Year>1990</Year>
                  <ArticleTitle Language="En">Centrally administered opioid antagonists, nor-binaltorphimine, 16-methyl cyprenorphine, and Mr2266, suppress intake of a sweet solution</ArticleTitle>
                  <JournalTitle>Pharmacol Biochem Behav.</JournalTitle>
                  <VolumeID>35</VolumeID>
                  <FirstPage>69</FirstPage>
                  <LastPage>73</LastPage>
                  <Occurrence Type="PID">
                    <Handle>2315372</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK3cXhsFWlsrs%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/0091-3057(90)90206-W</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Calcagnetti DJ, Calcagnetti RL, Fanselow MS. Centrally administered opioid antagonists, nor-binaltorphimine, 16-methyl cyprenorphine, and Mr2266, suppress intake of a sweet solution.<Emphasis Type="Italic">Pharmacol Biochem Behav.</Emphasis> 1990;35:69–73.</BibUnstructured>
              </Citation>
              <Citation ID="CR100">
                <CitationNumber>100.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Spanagel</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TS</Initials>
                    <FamilyName>Shippenberg</FamilyName>
                  </BibAuthorName>
                  <Year>1993</Year>
                  <ArticleTitle Language="En">Modulation of morphine-induced sensitization by endogenous κ opioid systems in the rat</ArticleTitle>
                  <JournalTitle>Neurosci Lett.</JournalTitle>
                  <VolumeID>153</VolumeID>
                  <FirstPage>232</FirstPage>
                  <LastPage>236</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8392157</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK3sXksVWgtbY%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/0304-3940(93)90329-J</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Spanagel R, Shippenberg TS. Modulation of morphine-induced sensitization by endogenous κ opioid systems in the rat.<Emphasis Type="Italic">Neurosci Lett.</Emphasis> 1993;153:232–236.</BibUnstructured>
              </Citation>
              <Citation ID="CR101">
                <CitationNumber>101.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>KL</Initials>
                    <FamilyName>Williams</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MHC</Initials>
                    <FamilyName>Ko</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KC</Initials>
                    <FamilyName>Rice</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JH</Initials>
                    <FamilyName>Woods</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Effect of opioid receptor antagonists on hypothalamic-pituitary-adrenal activity in rhesus monkeys</ArticleTitle>
                  <JournalTitle>Psychoneuroendocrinology</JournalTitle>
                  <VolumeID>28</VolumeID>
                  <FirstPage>513</FirstPage>
                  <LastPage>528</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12689609</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXis12htLw%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0306-4530(02)00037-9</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Williams KL, Ko MHC, Rice KC, Woods JH. Effect of opioid receptor antagonists on hypothalamic-pituitary-adrenal activity in rhesus monkeys.<Emphasis Type="Italic">Psychoneuroendocrinology</Emphasis>. 2003;28:513–528.</BibUnstructured>
              </Citation>
              <Citation ID="CR102">
                <CitationNumber>102.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Narita</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Kishimoto</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Ise</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Yajima</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Misawa</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Suzuki</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">Direct evidence for the involvement of the mesolimbic κ-opioid system in the morphine-induced rewarding effect under an inflammatory pain-like state</ArticleTitle>
                  <JournalTitle>Neuropsychopharmacology</JournalTitle>
                  <VolumeID>30</VolumeID>
                  <FirstPage>111</FirstPage>
                  <LastPage>118</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15257306</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXhtVyisbrF</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/sj.npp.1300527</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Narita M, Kishimoto Y, Ise Y, Yajima Y, Misawa K, Suzuki T. Direct evidence for the involvement of the mesolimbic κ-opioid system in the morphine-induced rewarding effect under an inflammatory pain-like state.<Emphasis Type="Italic">Neuropsychopharmacology</Emphasis>. 2005;30:111–118.</BibUnstructured>
              </Citation>
              <Citation ID="CR103">
                <CitationNumber>103.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>RL</Initials>
                    <FamilyName>Joynes</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JW</Initials>
                    <FamilyName>Grau</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Instrumental learning within the spinal cord: III. Prior exposure to noncontingent shock induces a behavioral deficit that is blocked by an opioid antagonist</ArticleTitle>
                  <JournalTitle>Neurobiol Learn Mem.</JournalTitle>
                  <VolumeID>82</VolumeID>
                  <FirstPage>35</FirstPage>
                  <LastPage>51</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15183169</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXks1ekur0%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.nlm.2004.04.001</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Joynes RL, Grau JW. Instrumental learning within the spinal cord: III. Prior exposure to noncontingent shock induces a behavioral deficit that is blocked by an opioid antagonist.<Emphasis Type="Italic">Neurobiol Learn Mem.</Emphasis> 2004;82:35–51.</BibUnstructured>
              </Citation>
              <Citation ID="CR104">
                <CitationNumber>104.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>HY</Initials>
                    <FamilyName>Cheng</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SR</Initials>
                    <FamilyName>Laviolette</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Kooy</FamilyName>
                    <Particle>van der</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JM</Initials>
                    <FamilyName>Penninger</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">DREAM ablation selectively alters THC place aversion and analgesia but leaves intact the motivational and analgesic effects of morphine</ArticleTitle>
                  <JournalTitle>Eur J Neurosci.</JournalTitle>
                  <VolumeID>19</VolumeID>
                  <FirstPage>3033</FirstPage>
                  <LastPage>3041</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15182311</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1111/j.0953-816X.2004.03435.x</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Cheng HY, Laviolette SR, van der Kooy D, Penninger JM. DREAM ablation selectively alters THC place aversion and analgesia but leaves intact the motivational and analgesic effects of morphine.<Emphasis Type="Italic">Eur J Neurosci.</Emphasis> 2004;19:3033–3041.</BibUnstructured>
              </Citation>
              <Citation ID="CR105">
                <CitationNumber>105.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Mizoguchi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RJ</Initials>
                    <FamilyName>Leitermann</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Narita</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Nagase</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Suzuki</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LF</Initials>
                    <FamilyName>Tseng</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Region-dependent G-protein activation by κ-opioid receptor agonists in the mouse brain</ArticleTitle>
                  <JournalTitle>Neurosci Lett.</JournalTitle>
                  <VolumeID>356</VolumeID>
                  <FirstPage>145</FirstPage>
                  <LastPage>147</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14746884</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXnvVahtg%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.neulet.2003.09.034</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Mizoguchi H, Leitermann RJ, Narita M, Nagase H, Suzuki T, Tseng LF. Region-dependent G-protein activation by κ-opioid receptor agonists in the mouse brain.<Emphasis Type="Italic">Neurosci Lett.</Emphasis> 2004;356:145–147.</BibUnstructured>
              </Citation>
              <Citation ID="CR106">
                <CitationNumber>106.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Fan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Tien</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Tanaka</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Enhanced binding of norbinaltorphimine to κ-opioid receptors in rats dependent on butorphanol</ArticleTitle>
                  <JournalTitle>J Neurosci Res.</JournalTitle>
                  <VolumeID>72</VolumeID>
                  <FirstPage>781</FirstPage>
                  <LastPage>789</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12774318</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXks1GlsL0%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/jnr.10578</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Fan L, Tien L, Tanaka S, et al. Enhanced binding of norbinaltorphimine to κ-opioid receptors in rats dependent on butorphanol.<Emphasis Type="Italic">J Neurosci Res.</Emphasis> 2003;72:781–789.</BibUnstructured>
              </Citation>
              <Citation ID="CR107">
                <CitationNumber>107.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Cosentino</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Marino</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>DePonti</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1995</Year>
                  <ArticleTitle Language="En">Tonic modulation of neurotransmitter release in the guinea-pig myenteric plexus: effect of μ and κ opioid receptor blockade and of chronic sympathetic denervation</ArticleTitle>
                  <JournalTitle>Neurosci Lett.</JournalTitle>
                  <VolumeID>194</VolumeID>
                  <FirstPage>185</FirstPage>
                  <LastPage>188</LastPage>
                  <Occurrence Type="PID">
                    <Handle>7478234</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2MXntl2mur8%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/0304-3940(95)11757-N</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Cosentino M, Marino F, DePonti F, et al. Tonic modulation of neurotransmitter release in the guinea-pig myenteric plexus: effect of μ and κ opioid receptor blockade and of chronic sympathetic denervation.<Emphasis Type="Italic">Neurosci Lett.</Emphasis> 1995;194:185–188.</BibUnstructured>
              </Citation>
              <Citation ID="CR108">
                <CitationNumber>108.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>MH</Initials>
                    <FamilyName>Ossipov</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CJ</Initials>
                    <FamilyName>Kovelowski</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Wheeler-Aceto</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1996</Year>
                  <ArticleTitle Language="En">Opioid antagonists and antisera to endogenous opioids increase the nociceptive response to formalin: demonstration of an opioid<Emphasis Type="Italic">kappa</Emphasis> and<Emphasis Type="Italic">delta</Emphasis> inhibitory tone</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther.</JournalTitle>
                  <VolumeID>277</VolumeID>
                  <FirstPage>784</FirstPage>
                  <LastPage>788</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8627559</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK28XivFehsbo%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Ossipov MH, Kovelowski CJ, Wheeler-Aceto H, et al. Opioid antagonists and antisera to endogenous opioids increase the nociceptive response to formalin: demonstration of an opioid<Emphasis Type="Italic">kappa</Emphasis> and<Emphasis Type="Italic">delta</Emphasis> inhibitory tone.<Emphasis Type="Italic">J Pharmacol Exp Ther.</Emphasis> 1996;277:784–788.</BibUnstructured>
              </Citation>
              <Citation ID="CR109">
                <CitationNumber>109.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>I</Initials>
                    <FamilyName>Obara</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Mika</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MK-H</Initials>
                    <FamilyName>Schafer</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Przewlocka</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Antagonists of the κ-opioid receptor enhance allodynia in rats and mice after sciatic nerve ligation</ArticleTitle>
                  <JournalTitle>Br J Pharmacol.</JournalTitle>
                  <VolumeID>140</VolumeID>
                  <FirstPage>538</FirstPage>
                  <LastPage>546</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12970097</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXosFOgsLw%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/sj.bjp.0705427</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Obara I, Mika J, Schafer MK-H, Przewlocka B. Antagonists of the κ-opioid receptor enhance allodynia in rats and mice after sciatic nerve ligation.<Emphasis Type="Italic">Br J Pharmacol.</Emphasis> 2003;140:538–546.</BibUnstructured>
              </Citation>
              <Citation ID="CR110">
                <CitationNumber>110.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>AK</Initials>
                    <FamilyName>Baker</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TF</Initials>
                    <FamilyName>Meert</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Functional effects of systemically administered agonists and antagonists of μ, δ, and κ opioid receptor subtypes on body temperature in mice</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther.</JournalTitle>
                  <VolumeID>302</VolumeID>
                  <FirstPage>1253</FirstPage>
                  <LastPage>1264</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12183687</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XmsF2htL0%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1124/jpet.102.037655</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Baker AK, Meert TF. Functional effects of systemically administered agonists and antagonists of μ, δ, and κ opioid receptor subtypes on body temperature in mice.<Emphasis Type="Italic">J Pharmacol Exp Ther.</Emphasis> 2002;302:1253–1264.</BibUnstructured>
              </Citation>
              <Citation ID="CR111">
                <CitationNumber>111.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>FC</Initials>
                    <FamilyName>Tortella</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Echevarria</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AW</Initials>
                    <FamilyName>Lipkowski</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AE</Initials>
                    <FamilyName>Takemori</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PS</Initials>
                    <FamilyName>Portoghese</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JW</Initials>
                    <FamilyName>Holaday</FamilyName>
                  </BibAuthorName>
                  <Year>1989</Year>
                  <ArticleTitle Language="En">Selective kappa antagonist properties of nor-binaltrophimine in the rat seizure model</ArticleTitle>
                  <JournalTitle>Life Sci.</JournalTitle>
                  <VolumeID>44</VolumeID>
                  <FirstPage>661</FirstPage>
                  <LastPage>665</LastPage>
                  <Occurrence Type="PID">
                    <Handle>2538689</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaL1MXht1ymtb8%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/0024-3205(89)90470-0</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Tortella FC, Echevarria E, Lipkowski AW, Takemori AE, Portoghese PS, Holaday JW. Selective kappa antagonist properties of nor-binaltrophimine in the rat seizure model.<Emphasis Type="Italic">Life Sci.</Emphasis> 1989;44:661–665.</BibUnstructured>
              </Citation>
              <Citation ID="CR112">
                <CitationNumber>112.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Manzanares</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KJ</Initials>
                    <FamilyName>Lookingland</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SD</Initials>
                    <FamilyName>LaVigne</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KE</Initials>
                    <FamilyName>Moore</FamilyName>
                  </BibAuthorName>
                  <Year>1991</Year>
                  <ArticleTitle Language="En">Activation of tuberohypophysial dopamine neurons following intracerebroventricular administration of the selective kappa opioid receptor antagonist nor-binaltorphimine</ArticleTitle>
                  <JournalTitle>Life Sci.</JournalTitle>
                  <VolumeID>48</VolumeID>
                  <FirstPage>1143</FirstPage>
                  <LastPage>1149</LastPage>
                  <Occurrence Type="PID">
                    <Handle>1848341</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK3MXhtFGjsLg%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/0024-3205(91)90451-G</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Manzanares J, Lookingland KJ, LaVigne SD, Moore KE. Activation of tuberohypophysial dopamine neurons following intracerebroventricular administration of the selective kappa opioid receptor antagonist nor-binaltorphimine.<Emphasis Type="Italic">Life Sci.</Emphasis> 1991;48:1143–1149.</BibUnstructured>
              </Citation>
              <Citation ID="CR113">
                <CitationNumber>113.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>McIntosh</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Kane</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Parratt</FamilyName>
                  </BibAuthorName>
                  <Year>1992</Year>
                  <ArticleTitle Language="En">Effects of selective opioid receptor agonists and antagonists during myocardial ischaemia</ArticleTitle>
                  <JournalTitle>Eur J Pharmacol.</JournalTitle>
                  <VolumeID>210</VolumeID>
                  <FirstPage>37</FirstPage>
                  <LastPage>44</LastPage>
                  <Occurrence Type="PID">
                    <Handle>1318203</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK38Xns1Sqsg%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/0014-2999(92)90649-O</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>McIntosh M, Kane K, Parratt J. Effects of selective opioid receptor agonists and antagonists during myocardial ischaemia.<Emphasis Type="Italic">Eur J Pharmacol.</Emphasis> 1992;210:37–44.</BibUnstructured>
              </Citation>
              <Citation ID="CR114">
                <CitationNumber>114.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Llobel</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>ML</Initials>
                    <FamilyName>Laorden</FamilyName>
                  </BibAuthorName>
                  <Year>1997</Year>
                  <ArticleTitle Language="En">Effects of μ-, δ-, and κ-opioid antagonists in atrial preparations from failing human hearts</ArticleTitle>
                  <JournalTitle>Gen Pharmacol.</JournalTitle>
                  <VolumeID>28</VolumeID>
                  <FirstPage>371</FirstPage>
                  <LastPage>374</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9068975</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2sXltVSmsrg%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Llobel F, Laorden ML. Effects of μ-, δ-, and κ-opioid antagonists in atrial preparations from failing human hearts.<Emphasis Type="Italic">Gen Pharmacol.</Emphasis> 1997;28:371–374.</BibUnstructured>
              </Citation>
              <Citation ID="CR115">
                <CitationNumber>115.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>Z</Initials>
                    <FamilyName>Cao</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Liu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DM</Initials>
                    <FamilyName>VanWinkle</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Activation of δ- and κ-opioid receptors by opioid peptides protects cardiomyocytes via K<Subscript>ATP</Subscript> channels</ArticleTitle>
                  <JournalTitle>Am J Physiol Heart Circ Physiol.</JournalTitle>
                  <VolumeID>285</VolumeID>
                  <FirstPage>H1032</FirstPage>
                  <LastPage>H1039</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12730057</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXnsVGnurw%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Cao Z, Liu L, VanWinkle DM. Activation of δ- and κ-opioid receptors by opioid peptides protects cardiomyocytes via K<Subscript>ATP</Subscript> channels.<Emphasis Type="Italic">Am J Physiol Heart Circ Physiol.</Emphasis> 2003;285:H1032-H1039.</BibUnstructured>
              </Citation>
              <Citation ID="CR116">
                <CitationNumber>116.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>GJ</Initials>
                    <FamilyName>Carey</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Bergman</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Enadoline discrimination in squirrel monkeys: effects of opioid agonists and antagonists</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther.</JournalTitle>
                  <VolumeID>297</VolumeID>
                  <FirstPage>215</FirstPage>
                  <LastPage>223</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11259547</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXisVSrsbw%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Carey GJ, Bergman J. Enadoline discrimination in squirrel monkeys: effects of opioid agonists and antagonists.<Emphasis Type="Italic">J Pharmacol Exp Ther.</Emphasis> 2001;297:215–223.</BibUnstructured>
              </Citation>
              <Citation ID="CR117">
                <CitationNumber>117.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>DC</Initials>
                    <FamilyName>Jewett</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JH</Initials>
                    <FamilyName>Woods</FamilyName>
                  </BibAuthorName>
                  <Year>1995</Year>
                  <ArticleTitle Language="En">Nor-binaltorphimine: an ultra-long acting kappa-opioid antagonist in pigeons</ArticleTitle>
                  <JournalTitle>Behav Pharmacol.</JournalTitle>
                  <VolumeID>6</VolumeID>
                  <FirstPage>815</FirstPage>
                  <LastPage>820</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11224385</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK28XhtVSgtb0%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Jewett DC, Woods JH. Nor-binaltorphimine: an ultra-long acting kappa-opioid antagonist in pigeons.<Emphasis Type="Italic">Behav Pharmacol.</Emphasis> 1995;6:815–820.</BibUnstructured>
              </Citation>
              <Citation ID="CR118">
                <CitationNumber>118.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>MJ</Initials>
                    <FamilyName>Picker</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Mathewson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RM</Initials>
                    <FamilyName>Allen</FamilyName>
                  </BibAuthorName>
                  <Year>1996</Year>
                  <ArticleTitle Language="En">Opioids and rate of positively reinforced behavior: III. Antagonism by the long-lasting kappa antagonist norbinaltorphimine</ArticleTitle>
                  <JournalTitle>Behav Pharmacol.</JournalTitle>
                  <VolumeID>7</VolumeID>
                  <FirstPage>495</FirstPage>
                  <LastPage>504</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11224446</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2sXmsF2rtA%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Picker MJ, Mathewson C, Allen RM. Opioids and rate of positively reinforced behavior: III. Antagonism by the long-lasting kappa antagonist norbinaltorphimine.<Emphasis Type="Italic">Behav Pharmacol.</Emphasis> 1996;7:495–504.</BibUnstructured>
              </Citation>
            </Bibliography>
          </ArticleBackmatter>
        </Article>
      </Issue>
    </Volume>
  </Journal>
</Publisher>
